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Abstract
DCE-MRI is an important technique in the study of small animal cancer models
because its sensitivity to vascular changes opens the possibility of quantitative assessment of
early therapeutic response. However, extraction of physiologically descriptive parameters from
DCE-MRI data relies upon measurement of the vascular input function (VIF), which represents
the contrast agent concentration time course in the blood plasma. This is difficult in small
animal models due to artifacts associated with partial volume, inflow enhancement, and the
limited temporal resolution achievable with MR imaging. In this work, the development of a
suite of techniques for high temporal resolution, artifact resistant measurement of the VIF in
mice is described. One obstacle in VIF measurement is inflow enhancement, which decreases
the sensitivity of the MR signal to the presence of contrast agent. Because the traditional
techniques used to suppress inflow enhancement degrade the achievable spatiotemporal
resolution of the pulse sequence, improvements can be achieved by reducing the time required
for the suppression. Thus, a novel RF pulse which provides spatial presaturation
contemporaneously with the RF excitation was implemented and evaluated. This maximizes the
achievable temporal resolution by removing the additional RF and gradient pulses typically
required for suppression of inflow enhancement. A second challenge is achieving the temporal
resolution required for accurate characterization of the VIF, which exceeds what can be
achieved with conventional imaging techniques while maintaining adequate spatial resolution
and tumor coverage. Thus, an anatomically constrained reconstruction strategy was developed
that allows for sampling of the VIF at extremely high acceleration factors, permitting capture of
the initial pass of the contrast agent in mice. Simulation, phantom, and in vivo validation of all
components were performed. Finally, the two components were used to perform VIF
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measurement in the murine heart. An in vivo study of the VIF reproducibility was
performed, and an improvement in the measured injection-to-injection variation was observed.
This will lead to improvements in the reliability of quantitative DCE-MRI measurements and
increase their sensitivity.
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1 Hypothesis and Specific Aims
Tumor growth and progression is intertwined with the growth and development of its
associated microvasculature (1). As a result of this relationship, vascular changes in response to
therapy are desirable endpoints in preclinical studies of novel interventions (2). Dynamiccontrast enhanced (DCE) magnetic resonance imaging (MRI) enables interrogation of the
microvasculature by investigating the dynamics of the uptake and clearance of an exogenous
contrast agent, which will be altered by the characteristics of the vasculature in and around
tumors (3). DCE-MRI is used both clinically, in the diagnosis (4) and in treatment response
monitoring of cancer (5), and investigationally (6-8) in humans, as well as in animal models of
disease, with unique and prominent challenges found in the latter.
Quantitative analysis of DCE-MRI data frequently uses pharmacokinetic models(9) to
relate the uptake of contrast agent into tissue to the concentration time course in the blood
plasma, known as the vascular input function (VIF), and subsequently producing a set of
pharmacokinetic parameters. These descriptive parameters permit expressing DCE-MRI data
as physiologically meaningful parameters which are related to quantities such as microvascular
volume, flow and permeability. Accurate and precise measurement of the VIF, although
required for accurate and reproducible parameter measurement, is challenging. Blood vessels
are not ideal locations in which to acquire MR data, as artifacts are associated with flowing
blood; these artifacts are dependent on the orientation of the blood vessel with regard to the
slice and are thus unpredictable. The small size of blood vessels can introduce substantial
partial volume effects that depend upon the relationship between the vessel and the acquisition
matrix, again resulting in unpredictability. Additionally, small animals have low blood
volumes and fast heart rates (over 300 bpm(10)). This introduces very rapid VIF kinetics,
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placing difficult demands on the spatial and temporal resolution of the VIF
measurement. These demands are difficult to meet while also providing adequate sampling of
the tumor tissues.
The precision of VIF measurements needs to be increased to improve the precision of
pharmacokinetic parameter measurements in small animal imaging. The objective of this
research is to develop methods for measuring the VIF in a manner that satisfies the need for
both high temporal sampling rates and freedom from artifacts. For the sake of providing a
basis for quantitative comparison of the measurements, it is convenient to express the VIF as a
set of parameters fit to a biexponential model. We hypothesize that when VIFs measured in
the heart using a highly subsampled acquisition and reconstruction strategy and flow
suppressive RF excitation are compared to VIFs measured in cerebral vessels, subsecond
temporal resolution of the VIF will be achieved and reduced coefficients of variance of the
biexponential parameters will be achieved. This hypothesis was tested in the following
specific aims:
1. Develop, characterize, and test a novel RF excitation pulse for flow suppression.
A family of RF pulses that produce spoiled regions adjacent to the primary slice were
developed. These provided spatial presaturation in the regions adjacent to the slice, allowing
for steady state imaging of inflowing spins, reducing the flow enhancement effect. The
efficacy of the pulse for the suppression of inflow enhancement was demonstrated in
simulations, phantom, and in vivo, and an improvement in the sensitivity of the MR signal
measurement to the presence of contrast agent was demonstrated.
2. Develop, characterize, and test a novel constrained reconstruction technique to
allow analysis of data from a highly undersampled data set. A novel constrained
reconstruction technique which permits measurement of the signal in regions of interest within
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a slice in the heart using very large undersampling factors was developed. Simulations
and in vivo data testing was performed to demonstrate that the algorithm provides an accurate
interpretation of the acquired data in the presence of both dynamic contrast enhancement and
cardiac motion.
3. Compare the characteristics of VIFs in a population of healthy mice using both
conventional and developed techniques. A population of eight mice was individually
injected with contrast agent and the resulting VIFs were measured. Each mouse was injected
three times with contrast agent, and a sufficient delay was allowed between injections for
clearance of the contrast agent from blood and soft tissue. The coefficients of variations (CV)
of a parametric representation of the VIF were compared to determine the intra-subject
reproducibility of the pharmacokinetic parameters.
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2 Introduction
2.1 Dynamic Contrast Enhanced MRI
Pathological conditions frequently involve the microvasculature and associated blood
flow of the affected tissues. Angiogenesis is a prominent example from cancer models, for
without the development of new blood vessels, tumors are incapable of growth beyond the
diffusion range of oxygen (1), which is a few tenths of a millimeter (11). The growth and
decay of the tumor vasculature can therefore provide information about the response of tumors
to therapy, and the use of non-invasive imaging modalities to probe the microvascular
characteristics of tissue is critical to biomedical research (2). This may be achieved by
exploiting the fact that vessels produced by tumors are often malformed and leaky, resulting in
hyperpermeability to small molecules, such as contrast agents (12), producing signal changes
which may be observed using advanced imaging techniques.
MRI is widely used for non-invasive investigation of pathology because of its excellent
soft tissue contrast and sensitivity to a wide variety of biochemical effects (13). In particular,
MRI may be used to dynamically observe changes in tissue contrast due to the uptake of
exogenous contrast agents. Dynamic Contrast Enhanced-MRI is achieved by exploiting the T1shortening effects of contrast agents, while a focus on the T2*-shortening effects is the basis for
Dynamical Susceptibility Contrast (DSC)-MRI. Both techniques are used in the study of
microvasculature, with DSC more commonly used in studies of blood volume and flow in the
brain with an intact blood brain barrier, and DCE generally used in studies of microvascular
permeability and perfusion in the body (14,15) and in brain tumors(16). This work is primarily
concerned with DCE-MRI applications in small animal models of cancer.
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DCE-MRI has been found useful in the management of many tumor types,
which underscores its relevance to a wide variety of models. It has been found, in either
qualitative or quantitative form, to be a sensitive and specific technique for the detection and
staging of disease, with examples including, but not limited to, breast cancer (17), prostate
cancer (18), and bone marrow lesions (19), and in many cases it has been shown to be effective
for the monitoring of patient response to therapy (20,21). Quantification becomes more
important preclinically, in which changes in vasculature measured using DCE-MRI are a
common endpoint in drug development (2), and precise measurements are essential for reliable
evaluation of efficacy. Quantification of DCE-MRI has shown much recent use in relation to
the development of antiangiogenic drugs (22,23), response to radiation (24), and chemotherapy
(25,26).

2.2 Data acquisition and analysis for quantitative DCE-MRI
A typical DCE-MRI protocol for quantification of dynamics consists of several
sequences for localization and anatomic imaging. After these images are acquired, the precontrast T1 of the tumor is often measured before dynamic data are acquired to enable
calculation of the contrast agent concentration, although an assumed value may be used (27).
Finally, a dynamic series of images is acquired, typically with a short-TR spoiled gradient echo
sequence, during which a bolus of contrast agent is injected after the acquisition of a few
baseline images. This sequence allows both a relatively high frame rate and short echo times,
which minimizes T2*-related dephasing produced by the contrast agent. The dynamic protocol
must strike a difficult balance between high temporal resolution for measuring the uptake
dynamics, spatial coverage, and high spatial resolution, which is required due to the
heterogeneity of tumor tissue (28). Relatively fast uptake and clearance is expected in areas of
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highly permeable vasculature, such as in many tumors, while in healthy tissue contrast
agent extravasates and clears at a slower rate (29).
The analysis and interpretation of the dynamic MR data is most easily performed in
terms of the contrast agent concentration, a physical quantity, as opposed to the MR signal,
which has an arbitrary meaning and a non-linear relationship to the concentration. Because the
MR signal depends indirectly on the contrast agent concentration through the relaxation rates,
the path from MR signal to final measurement of the vascular state requires several steps and
relies upon several measured, known, or assumed parameters.
In order to calculate the concentration levels in vivo, the signal time course is measured
from the dynamically acquired images. For an ideal spoiled gradient echo sequence with
perfect spoiling of the signal between excitations, the signal is given by the equation (30):

(Eq. 2.1)
where S is the measured signal, ρ is a term including the spin density, as well the receiver gain
and other constant factors, TE is the echo time, TR is the repetition time, θ is the excitation flip
angle, and T1 and T2* are the longitudinal and transverse relaxation times, respectively. When
the signal changes dynamically, this is due to temporal dependence in T1, caused in turn by the
changes in the contrast agent concentration. Often the effects of a temporally varying T2* are
ignored due to the use of a short echo time; ignoring these effects simplifies the necessary
calculations (31).
The above equation can be solved for the T1 of tissue after contrast agent
administration, assuming that baseline values for the tissue signal and its longitudinal relation
time are known. The equation for the time dependant T1 becomes
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, where
(Eq 2.2)

(Eq 2.3)

and S(t) is the dynamically measured signal, S0 is the baseline signal, T1,0 is the native T1 of the
tissue, θ is the flip angle, and TR is the repetition time. The concentration can be calculated
using the relation:
1

()

T1 t

=

()

1
+ rC t
T1,0 1

(Eq 2.4)

where C(t) is the contrast agent concentration as a function of time, and r1 is the contrast agent
T1 relaxivity. This is a parameter of the contrast agent that describes the agent’s effect on the
T1 relaxation rate. Values for this parameter, reported for human blood at 3T are 3.3 M-1s-1for
gadopentetate dimeglumine, 3.6 M-1s-1for gadobutrol, and are 6.3 M-1s-1 for gadobenate
dimeglumine.

2.3 Pharmacokinetic modeling of DCE-MRI Data
Three different modes are found in the analysis of dynamic uptake data: qualitative
curve shape analysis, semi-quantitative analysis, and quantitative analysis. Although it is
sometimes possible to interpret the shape of the tissue-enhancement curve directly to provide
diagnostic information, this is not reproducible across imaging systems (32). It also relies on
non-quantitative, subjective assessment and is thus not a useful approach for small animal
DCE-MRI studies. Visual changes in enhancement curves are also much less sensitive
indicators of changes in the tumor than quantitative analysis; a difference of approximately
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50% in quantitative measurements is required to produce a perceptible qualitative
change (33). As a result, small animal studies, which hope to detect smaller and earlier
changes in the tumors require more rigorous quantification that is more sensitive and
reproducible than curve-shape analysis provides.
Semi-quantitative analysis relies upon the calculation of an empirically useful
descriptive parameter from the tissue uptake curve. These parameters include the initial area
under the curve (IAUC) and the initial slope of the enhancement curve (34). Although they do
not have directly interpretable physiological meanings, they have been used for many clinical
applications (34). However, semi-quantitative analysis has been found to be less reproducible
than a full kinetic analysis (35), and the lack of interpretability has led to a desire for analyses
that are based on the physiology of tissue.
Quantitative analysis (34) is based upon simple physiological models which permit
transforming the contrast uptake curves measured in tissue into physically meaningful terms.
These models provide parameters which are sensitive to flow, permeability, and blood volume,
although in some models their effects may become indistinguishable.
The models most frequently cited in the literature were adapted from the work of Kety,
which is based in indicator-dilution theory (36), and the same models are generally used in both
human and small animal imaging. Although many variations are present, the most common
models present in literature related to the Tofts-Kermode model, which as presented here uses a
consensus terminology from many early workers in the field of DCE-MRI (3). This model is
derived from compartmental assumptions, that is, that blood and tissue are two well-mixed,
disjoint units that exchange contrast agent, shown in Figure 2-1. The extracellular components
of blood and tissue are assumed to be two pools which exchange contrast agent according to a
differential equation(3):
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(Eq 2.5)
where KTrans represents the forward transfer constant, a mixed term describing both flow and
perfusion effects, and the concentrations in the blood plasma and tissue are Cp and CT,
respectively. The fractional extracellular extravascular volume is given by ve.
The most general expression for KTrans is (29):
(Eq 2.6)
where F is the blood flow, Hct is the hematocrit, ρ is the tissue density, and PS is the
permeability-surface area product. In the case of high perfusion, uptake is limited by flow and
. In the case of high flow,

. When neither flow nor

perfusion dominates, the two quantities are not distinguishable (3), in tumors the mixed case
generally applies(8). An alternative parameterization with a second rate constant in place of
the EES volume,

is also quite common. This allows consideration of the

dynamics in terms of the mean residence time of the contrast agent instead of the volume of the
EES. Tissue and blood plasma contrast agent concentrations are denoted by Ct and Cp,
respectively. The blood plasma concentration is frequently given a special name, either the
arterial input function (AIF), or the vascular input function (VIF). We use the term VIF
exclusively in this work. The VIF represents the blood supply of the tissue, which is typically
approximated by a measurement performed in a nearby artery or vein. These equations assume
a lipophobic contrast agent that does not penetrate the cell walls; which leads to the factors
accounting for the extracellular volume and the hematocrit. The convolution equation below is
a solution to Eq. 2.5 (3):
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(Eq 2.7)

KTrans
KTrans/ve

Extracellular
Space
Extravascular
Intracellular
Space

Blood
Plasma
Intracellular
Spaces
pace

Figure 2-1 Diagram showing the differential compartmental model.
In practice, use of the two parameter model is often associated with spuriously large
values for KTrans, which result from the presence of blood vessels in the tissue voxel; this is
known as the pseudopermeability artifact (37). A threshold of 1.2 min-1 is commonly used for
identifying voxels that are corrupted by pseudopermeability (16). This criteria is strangely
uncontroversial in the DCE-MRI literature, however, voxels which are only partially affected
will not be identified by thresholding (38). No alternate threshold for small animal imaging has
been proposed. These effects may be mitigated by the use of the extended model (39,40),
where vb is the fractional intravascular space:
(Eq 2.8)
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An implicit assumption of this model is that there is a single T1 behavior for both the
intravascular space and the EES, which is equivalent to assuming fast proton exchange between
vessels and tissue. This assumption has been experimentally tested and it was concluded that
the assumption held in most tissues, with a notable exception in the cerebrovasculature
resulting from the blood-brain barrier (41).
A simplification of the three-parameter model was put forth by Li (42), called the FirstPass Leakage Profile (FPLP) model, which only analyzes the first pass of the contrast agent in
the blood. This simplifies calculations of pharmacokinetic parameters and allows for shortened
acquisition times, which may be useful in cases of severe motion or a non-compliant patient.
The simplified model assumes that no appreciable amount of contrast backflows from tissue
into the blood over this interval, that is, neglecting kep. This model is not commonly used in
small animal models.
Other models that are not based on compartmental assumptions have been proposed,
most notably the adiabatic approximation to the tissue homogeneity model (AATH) (43,44),
where
(Eq 2.9)

(Eq 2.10)

In the above equation, Tc is the time that contrast agent spends in the capillary before entering
the tissue, and other quantities are as previously defined. This model fails to be a
compartmental model because it does not include the assumption that blood is well-mixed (45).
Instead, it assumes that the blood dynamics occur on a much faster timescale than the exchange
of contrast agent between blood and tissue. If the tissue is sampled faster than Tc, this model is
able to separate flow and perfusion effects. When the temporal sampling rate is slower than Tc,
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the model becomes indistinguishable from the three-parameter two-compartment
model. In humans, values for Tc have been measured on the order of 40 s in a particular tumor
model (46); in rats, values of approximately 11 s have been measured (47) using dynamic CT.
The tissue homogeneity model itself is rarely used because it does not have a closed form
solution when written as a function of time (43,48). Another variation of this model includes a
distribution of capillary transit times within a single voxel (46).
Some investigators have used models that rely on the same contrast agent dynamics, but
which explicitly account for the exchange of water between the intracellular space and the EES.
Conventionally, it is assumed that water exchange is in the so-called fast exchange limit, in
which water exchanges sufficiently rapidly to only have a single T1 behavior in the voxel. This
form of modeling introduces an additional parameter that describes the exchange rate of
protons between the two components of tissue (49). The significance of these effects remains
controversial (41,50).
An alternative to the use of an explicit model is to perform a non-parametric
deconvolution to produce a residue function (51). This allows for improved fitting of the
concentration time courses by avoiding model errors during the deconvolution step. Although
interpretation of the residue curves for measurements of blood flow and blood volume is
commonly done in DSC-MRI (52), there has not yet been a method for interpreting
permeability in this context, other than fitting the residue curve itself to one of the
aforementioned models (51).
Limited comparisons have been performed between the various pharmacokinetic
models. Buckley performed a simulation study in which an independent model for blood
transport was used to compare both forms of the two compartmental model and the AATH to
the actual simulated values. The latter was capable of producing the most accurate results, but
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also had the most strenuous requirements for temporal sampling and was subject to
the most difficulties in fitting. The extended Toft’s model was found to avoid the
pseudopermeability artifact, but in general tended to overestimate KTrans and underestimate vp
(39).
Comparisons have also been performed using in vivo data. Harrar, et al. found in
glioma patients that the FPLP and the extended Tofts model provided comparable results, and
that both were considerably less sensitive to the pseudopermeability artifact than the twoparameter Tofts model (37). Haroon, et al., directly compared the FPLP and the two-parameter
Tofts model, and came to a similar conclusion regarding the presence of the
pseudopermeability artifact (38).

2.4 Uncertainty in the calculation of kinetic parameters
Fundamentally, the calculation of the pharmacokinetic parameters relies on two
measurements: the concentration time courses in tissue and that in blood. Uncertainty and
errors in those two measurements contribute to uncertainty and errors in the final calculated
parameters. Because concentration measurements in MRI are indirect, several quantities,
which are themselves subject to uncertainty, are required for precise and accurate calculation of
the pharmacokinetic parameters. These quantities include the baseline T1 of blood and tissue,
the flip angle used to excite the spins in the dynamic acquisition, the T1 relaxivity of the
contrast agent used, and the individual signal time courses of both tissue and blood (53).
The variations in the final pharmacokinetic parameters that result from errors in the
individual input parameters have been estimated by various investigators. While the contrast
agent relaxivity affects the absolute values of the parameters measured, it is constant across an
experiment and does not introduce imprecision into the final values (53). It has been argued
that the accuracy of the baseline T1 measurement is not a major factor in the accuracy and
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precision of the final kinetic parameter measurement. Specifically Dale, et al. (53),
found that uncertainties in measuring the baseline T1 resulted in a coefficient of variation (CV)
in the final kinetic parameters of between 5 to 6%, over a wide range of T1 and parameter
values, and Haacke, et al.(27) even found that reproducibility was enhanced by assuming a
constant value for T1. The effects of flip angle errors depend on the analysis performed, but
proper measurement of the transmit field strength B1 (e.g., (54)) and appropriate choice of
protocols can reduce the error to a few percent, and this is less problematic in small animal
imaging due to the small size of the RF coils (55).
Both the temporal sampling rate of tissue (56) and the spatial resolution (28) affect the
accuracy and precision of pharmacokinetic parameters. The effects of these factors were not
investigated in this work. However, the techniques presented here are anticipated to ease the
necessary protocol compromises by enabling optimization of the VIF measurement without
affecting the encoding of the tissue.

2.5 Uncertainty resulting from the VIF measurement
As one of the main components of the kinetic model, it should not be surprising that the
accuracy and precision of the VIF has a strong impact on the accuracy and precision of the
measured pharmacokinetic parameters, and these effects have been studied by several
investigators. The prominence of this measurement in the DCE-MRI literature, as opposed to
that in tissue or the common issues of quantifying contrast agent concentrations in MR, is due
to the fact that the measurement of the VIF presents unique artifacts beyond those associated
with the conversion of signal into concentration. Errors in the VIF will have substantial effects
on the accuracy and reproducibility of all pharmacokinetic parameters (11) and the VIF has
been identified as a major source of error in these parameters (57). Improved measurement of
the VIF is an important goal for improvements in the reliability of DCE-MRI. Because of the
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limitations imposed by partial volume effects, blood flow, and sampling
requirements, many groups have proposed strategies for improved measurement of the VIF
(58-63), and improved VIF measurement has been identified as an important need by the
Pharmacodynamic/Pharmacokinetic Technologies Advisory Committee for the UK (8,64). Key
contributors to the uncertainty in VIF measurement are partial volume effects due to the small
size of blood vessels, inflow enhancement due to blood flow, and inadequate temporal
resolution of VIF sampling. As will be discussed in the next few paragraphs, these effects are
estimated to produce errors and uncertainties in pharmacokinetic parameter measurements in
excess of 30%.
Partial volume and flow effects tend to scale the entire VIF (65), as a first order effect,
although distortion of the VIF due to partial volume effects has also been reported when the
amount of tissue in the voxel is above 30-40% (66). Uncertainty in the peak concentration
manifests directly as uncertainty in both KTrans and vb, and therefore variance of the
concentration amplitude appears directly as variance in both parameters (65), implying that
these artifacts tend to introduce unpredictable scaling into the measurement of pharmacokinetic
parameters. It has also been estimated that uncertainties in the measurement of kinetic
parameters of over 20% have been attributed to uncertainties in the measurement of the
VIF (67).
Another commonly studied source of error in the VIF is insufficient temporal sampling
of the VIF. For example, Karmonik and Jackson (68) found that sampling at least once every 4
seconds in humans is associated with variations in excess of 10% into the measurement of
KTrans and over 30% in vb; these figures would likely be higher for the faster kinetics of small
animal models. Using parameter estimates typical of human breast cancer, Henderson et al.
recommended that the VIF be sampled at least once per second in order to reduce the 95%
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confidence interval of kinetic parameter measurements to within 10% of the true
value for all three parameters in the extended Toft’s model (56), and this is a widely accepted
guideline (55). Notably, the needs for sampling of the uptake in tissue are considerably
different than in blood: much more modest temporal resolution and higher spatial resolution are
preferred, and this has resulted in suggestions that acquisition schemes be capable of separate
behaviors for blood and tissue; this is achieved with the techniques proposed in this work.
Faster VIF sampling may be required in mice than in humans due to the smaller blood volumes
and faster heart rates, exacerbating this challenge (10,69), although no specific criteria has been
established.
Additional artifacts arise from considering the use of Cartesian phase encoding in MR.
The use of conventional phase encoding when measuring the VIF may also lead to substantial
artifacts in the measurement of pharmacokinetic parameters, because the bolus of contrast
agent may arrive at any time during the acquisition of k-space. This can lead to distortion of
VIF solely due to the arrival of the contrast agent arriving while sampling the edge of k-space.
Roberts, et al., found that this introduces uncertainties in the measurement of KTrans of
approximately 10% and in excess of 50% in vp (70). This is consistent with the recent work by
Cheng (65), which reported that the errors in pharmacokinetic parameter measurements
associated with incorrect sampling of the initial passage were at least 10%.

2.6 Previous approaches to measuring the VIF
Due to the peculiar challenges of VIF measurement in mice, many approaches have
been put forth in an attempt to solve what has been described as a “notoriously difficult
problem” (71). Early approaches to VIF measurement included blood draws (72); these are
unsuitable for small animal imaging due to insufficient mouse blood volume (71). Both
population average VIFs (72) and assumed functional forms (73) have also been used, although
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these methods are discouraged because they may not appropriately describe the
kinetics within each individual (55,74) and have been found to provide less reproducible results
than individual measurements (75). However, it has been argued that population averaging may
be appropriate in some cases with highly distal tumors, where dispersion of the VIF reduces
individual variations (76). It seems unlikely that dispersion comparable to that encountered
along the entire length of a human leg would be encountered in most murine applications, and
because of the anatomic specificity, this is not a general solution to the problem of VIF
measurement.
One of the most common and natural methods for subject-specific measurement of the
VIF is to measure in a blood vessel local to the tissue of interest, however, this approach is not
without the limitations of flow and partial volume effects which can also substantially affect
quantification (77). In addition, identification of blood vessels in which to perform the
measurement is problematic. Manual identification is both tedious and subjective; while
automatic techniques (78) may address this issue, they are still unable to address fundamental
artifacts, such as partial volume and inflow effects, within the data.
In rats, a highly invasive technique has been used which provides accurate measurement
of the VIF (79), that involved inserting a shunt off of the carotid artery and running the shunt
through an RF coil. This presented none of the difficulties associated with blood vessel
identification or partial volume effects, but was obviously highly invasive. There have been no
reports of the use of this technique in mice, and to do so in a large study would be costly, and to
use it in a longitudinal study would raise issues of the long term effects of the shunt on the
subject.
Recently, some groups have proposed using a reference tissue method, which infers a
VIF from the contrast agent dynamics in normal tissue (59,63,71,80,81). This is not
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susceptible to the limitations of measurements in local blood vessels, but it requires
assuming a pharmacokinetic parameter value for healthy tissue, such as muscle, and any
variations of the tissue will be transferred to measurements in tumor. In addition, this
technique has not been found to provide superior reproducibility as compared to measurement
in a local blood vessel (63).
A direct approach to measurement of the VIF was used by Pickup, et al.(10) They
acquired very low-resolution images (24 phase encode lines) of the heart during contrast agent
injection, achieving a temporal resolution as low as 2 s but with only coverage of a single slice.
This allows the measurement of the VIF in a structure that is sufficiently large to avoid in-plane
and through-plane partial volume effects, as well as improved noise performance resulting from
the large size of the heart. Images were prospectively gated using an ECG signal. This
technique has been used to measure the pharmacokinetics of tumors (10,69), but it requires the
tumor to be in the same plane as the heart, compromising both tumor coverage and spatial
resolution of the tumor kinetics.
Similarly, McIntyre, et al. (60), used a dedicated transceiver coil around the tail to
perform measurement of the VIF in the tail veins in rat models. A saturation-recovery protocol
was used to provide suppression of inflow enhancement; they were able to acquire three slices
of tumor tissue in the delay between saturation and imaging of the tail. Imaging in the tail
allowed high resolution through the use of a small field-of-view (FOV), and the saturationrecovery approach provided flow suppression. However, the temporal resolution and coverage
of the tumor were both limited by the timing restrictions imposed by the saturation preparation
pulse: only three slices of tumor could be imaged, and temporal resolution for both the VIF and
tissue was only 6.7 s.
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A technique to rapidly sample signal from blood vessels was proposed by
Taylor, et al. (82). That work used a radial projection acquisition to measure the VIF in major
blood vessels from individual projections. This allowed measurement of the VIF each
repetition period, however, the partial volume correction was crude and approximate. Flow
suppression was performed using a saturation slab adjacent to the slice of interest, although at a
cost of extending the minimum TR of the sequence by over 20 ms. This reduced the rate of
tissue sampling from once every 9 s to once every 12 s, although the VIF sampling rate
remained faster than once every 80 ms.
No MR technique yet proposed has been able to provide high temporal resolution
measurements of the VIF in mice that are simultaneously insensitive to inflow enhancement
and partial volume artifacts. The objective of this work is to develop and test a novel approach
for VIF measurement in mice while satisfying these criteria. It is demonstrated that flow
suppression can be accomplished by applying spatial presaturation during excitation, which
does not require additional RF pulses, gradients, or delays, providing considerably faster flow
enhancement than is otherwise possible. Measurement in the left ventricle allows for
minimization of partial volume effects. Also, a constrained reconstruction technique that
allows measurement from an extremely reduced number of views is used to provide high
temporal resolution VIF sampling. Finally, these developments are applied to VIF
measurement in mice in an in vivo study of reproducibility.
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3 Specific Aim 1 – A composite RF pulse for flow
enhancement suppression
3.1 Introduction
As previously mentioned in §2.5 , inflow enhancement reduces the sensitivity of the
MR signal to contrast-related T1 alterations due to the spurious hyperintensity caused by fresh
spins entering the imaging plane. The partial replacement of saturated with fully relaxed spins
substantially reduces the signal sensitivity to T1 changes due to the addition of contrast agent.
The only effective counter to this artifact is to prepare spins with a non-trivial history of RF
pulses before they enter the area of interest.
Flow enhancement suppression is commonly accomplished using a 90° preparatory
pulse to saturate a wide region around the slice; this fully saturates the incoming magnetization
and avoids flow enhancement by suppressing the signal entirely. This prevents vascular
hyperintensity in images, but for quantification of vascular signals requires a delay to obtain a
useful signal level from blood, which compromises sequence timing. The requirement for
additional delays has compromised several approaches for VIF measurement employing flow
suppression. One such acquisition strategy acquires only a single slice containing both the
vascular structure of interest and the tumor (10). In an alternative approach, three tumor slices
may be acquired during the delay between saturation and excitation, as was done by McIntyre,
et al. (60). Both approaches ultimately restrict tumor coverage, and the use of discrete RF
pulses for preparation and measurement, along with their associated gradients, does not make
optimal use of time during the pulse sequence.
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Alternatively, presaturation can also be performed at a lower flip angle, which
requires multiple repetition periods to bring flowing blood into steady state, but which does not
necessitate the use of a delay. While a 90° pulse brings spins into steady state after a single
pulse (83), lower flip angles require multiple pulses (30). Because spins must experience more
pulses, this extends the width of the saturation region that spins must pass through in order to
reach steady state. However, in this work it is demonstrated that presaturation may be made a
very efficient part of the pulse sequence by combining the saturation and excitation
components into a single pulse and exploiting the slice select gradient for signal spoiling.

3.2 Theory
3.2.1 Desired slice profile
The efficiency of presaturation may be improved by combining separate excitation and
presaturation pulses into a single composite pulse. The slice-select gradient may be used to
spoil the signal excited in the presaturation region. This may be represented as a single slice
profile that describes the magnetization produced during both the excitation and saturation
phases of the pulse sequence. The regions excited for presaturation, where signal is both
excited and spoiled, may be represented as a section of the slice profile with uniform magnitude
and linear phase dependence. The resulting phase incoherence causes no net signal to be
produced in this region. The excitatory component corresponds to a segment with uniform
magnitude and a constant phase.
Because relatively shallow flip angles are used, the RF pulse has a Fourier relationship
to the desired slice profile (84). One possible slice profile, specified relative to the Larmour
frequency, (Figure 3-1a) is:
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(Eq. 3.1)

where ω1 is the bandwidth of the coherent region of the slice, and ω2 is the additional
bandwidth that is excited, but spoiled for flow enhancement suppression. The rate of phase
change over distance is given by

.

An alternative profile choice is to keep the direction of the phase gradient the same in
both saturation regions (Figure 3-1b):

(Eq. 3.2)

This profile is, in theory, equivalent to the first from a flow saturation perspective, however it
results in a different RF waveform, with some advantages and disadvantages.
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Figure 3-1 The two basic forms of the flow suppressive slice profile.
The profile generated by the symmetric pulse (Eq. 3.1) is shown in (a), while the
antisymmetric pulse (Eq. 3.2) generates (b). The only difference between the two profiles,
in principle, is the sign of the phase gradient in the spoiled region on one side.

3.2.2 RF waveform
Because the flip angles used in DCE-MRI are relatively small, the slice profile is related
by the Fourier transform to the desired RF waveform. For the first slice profile (Eq. 3.1, shown
in Figure 3-1a), the corresponding RF pulse is (85):
(Eq. 3.3)
The reversal of the phase gradient in the slice profile comes from the symmetry of the two
components that are time-shifted before and after the first term of the equation: one component
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is under-refocused by the rephasing gradient, the other is over-refocused. The pulse
which generates the asymmetric slice profile (Eq. 3.2, shown in Figure 3-1b) is:
(Eq 3.4)
We refer to the first pulse as a symmetric pulse because of the shape of its envelope; the second
pulse shape will be called an asymmetric pulse. Example asymmetric pulses are shown in
Figure 3-2 and symmetric pulses are shown in Figure 3-3.
The composite flow suppression pulse consists of two or three separate sinc pulses, each
exciting different regions of the slice.

Increasing the phase gradient in the sidebands

corresponds to increasing the shift between the centers of the pulses, which results in those
excited components being more over- or under- refocused by the slice rephase gradient. The
maximum phase gradient is limited by the duration of the RF pulse. Compared to the
symmetric pulse, the asymmetric pulse requires greater peak RF power and a higher RF slew
rate. However, because the high-power region of the RF pulse is more compact, with
appropriate hardware it would be possible to truncate the pulse more aggressively and shorten
the excitation time. This possibility was not explored in this work because very short duration
versions of the asymmetric pulse required more power than was achievable on the system
hardware.
The use of a sinusoidally modulated sinc pulse to achieve spatial suppression was
previously proposed by Doddrell, et al. (86) We have taken the further step of reducing the
time for the pulse by incorporating the spatial suppression and excitation components into a
single composite pulse, which further reduces the time required by the pulse.
When using a sinc pulse for excitation, one of the fundamental design decisions is the
number of zero-crossings of the truncated waveform. In this pulse, the number of zerocrossings of the component producing the coherent region provides the equivalent tradeoff
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between pulse duration and slice thickness; this decision restricts the timeshift of two
component pulses, limiting the maximum value of α. The saturation region width becomes
primarily limited by the peak RF power needed and the acceptable duration of the pulse, which
increases with the width of the saturation regions. The relative amplitudes and durations of all
pulse components are fixed in the raw pulse waveform because they are identically scaled
during excitation to achieve the desired flip angle. For this reason, it is convenient to refer to a
pulse by the ratio of the widths of the two regions, rather than an absolute width. We chose a
sinc pulse with three zero crossings on each side of the central lobe for consistency with the
equivalent 2D excitation pulse.
Although only integer values for α and ω2/ω1 are used in this study, this is not a
necessity. Because we investigate the effects of the saturation width in this work, the use of an
integer value for α allows for a natural increment of the saturation width in units of the coherent
slice thickness. The use of an integer for both parameters simplifies pulse construction because
it forces all three components of the pulse to have several zero-crossings in common, allowing
for simple construction of the pulse with a finite slew rate at the beginning and end of the pulse.
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Figure 3-2 Asymmetric pulses used in the simulations and measurements.
The pulses from the asymmetric family that were used are shown; units are specified as
γB1. Increasing the width of the sideband (a to c to e and b to d to f) both makes the
spoiling pulse more narrow and increases its amplitude. Increasing the separation of the
spoiling lobe and the main lobe (a to b, c to d, and e to f) corresponds to a larger phase
gradient in the resulting slice profile.
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Figure 3-3 Symmetric pulses used in the simulations and measurements.
The relationships between the sideband width and the degree of spoiling to the RF pulse
that were mentioned regarding the asymmetric pulse apply here. The prominent
imaginary components of the suppression lobes occur because the two pulses are centered
on a different frequency than the zero of the rotating reference frame; in the asymmetric
case the imaginary components of the two sub-pulses cancel. The peak amplitude of these
pulses is half that of the corresponding asymmetric pulse, as given in the Eq 3.3 and 3.4.
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3.3 Calculated slice profiles
3.3.1 Methods
To validate the theoretical slice profile calculation and to evaluate the artifacts resulting
from the truncation of the pulses, numerical simulations were performed of the composite RF
pulses by numerically solving the Bloch equation using Matlab (Mathworks, Natick, MA).
Simulations were performed by assuming a linear slice-encoding gradient for the duration of
the RF pulse, which was amplitude-reversed for 50% of the pulse duration immediately
afterwards. Stationary spins were simulated at 1024 evenly-spaced points along the gradient
providing to peak frequency offsets from -42 kHz to +42 kHz when the gradient was present.
The RF pulses simulated had ω2/ω1 of 1 through 5 and α = 1 and 2; both symmetric and
asymmetric pulses were used. The flip angle was 30°; the RF pulse amplitude was calibrated to
the appropriate area under the slice profile according to a Fourier relationship. Relaxation
effects were neglected due to the short (1 ms) pulse duration. The residual transverse and
longitudinal magnetization after the rephase gradient was plotted, as was the phase of the
transverse magnetization. The flip angle of the slice profile was calculated by taking the
arccosine of the ratio of the signal in the saturation band to the signal outside the excited
region; the standard deviation of the flip angle in the saturation band was calculated to estimate
the ripple in the profile. Example asymmetric pulses used are shown in Figure 3-2 and
symmetric pulses are shown in Figure 3-3.

3.3.2 Results
The calculated slice profiles are flat in each region of the profile, although a slight
artifact at the transition between the regions is observed in all three profiles, resulting from the
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truncation of the edges of the saturation pulses. The ripple in the saturation band was
equal for both symmetric and asymmetric pulses; it was ±0.15º for pulses with α = 1 and ±0.33º
for pulses with α = 2. Greater ripple, as well as an artifact at the transition of the regions, is
found in the profiles with a greater phase gradient. The artifacts do not vary with the width of
the saturation region because they are a Gibbs effect arising from the truncation of the RF
pulse, as opposed to cross-talk between the coherent and incoherent regions. The artifacts are
larger with the greater value of α because the pulse is truncated at a larger amplitude level of
the time-shifted component. A slight bowing of the profile is observed as the saturation width
increases; this is a change of less than 1.5º over the width of the profile shown. The profiles for
the asymmetric pulses are shown in Figure 3-4 and the symmetric pulse profiles are in Figure
3-5.
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Figure 3-4 Simulated slice profiles with from the asymmetric pulses.
The transverse magnetization of the slice profiles shows a flat response (a), which is
matched by the residual longitudinal magnetization (c). The 4π pulse shows some
artifacts at the transition between the coherent and the incoherent regions (b,d). The
phase profile is identical on both sides of the coherent region (e,f), as both sides are underrefocused by the slice select gradient.
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Figure 3-5 Simulated slice profiles from the symmetric pulses.
The magnitude of the slice profiles is comparable to those produced by the asymmetric
pulses, although close examination shows that the profiles are slightly less bowed. The
phase gradient changes direction on each side of the coherent region, due to one side
being over-refocused by the rephasing gradient.
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3.4 Calculated signals
3.4.1 Methods
The use of this RF pulse relies upon the assumption that widening the saturation region
does not change the net signal produced by the pulse. To test the stability of the signal as the
sideband width was increased, theoretical calculations were performed using the previously
tabulated slice profiles. To calculate the net signal, the signal at each point along the slice
profile was weighted according to the flip angle at that point in space according to the equation
for a steady state spoiled gradient echo sequence for four scenarios:
1) Full T1 relaxation
2) TR of 40, T1 of 700 ms
3) TR of 40, T1 of 1800 ms
4) TR of 40, T1 of 3500 ms
The fixed value of TR was chosen to match the TR used in the institutional small-animal DCEMRI protocol, which would be used as the basis for the VIF measurements in the final aim.
These weighted profiles were integrated to provide the simulated signal that would be
measured using a sinc pulse (i.e., ω2 = 0) and flow suppressive pulses with ω2 /ω1 = 1 to 5 and α
= 1 and 2. The simulated parameters are nominal parameters for in vivo measurement of blood,
blood with 0.2 mM of contrast agent, and water at 4.7 T. The flip angle of the profiles was 30º.

3.4.2 Results
The expected signal produced by the RF pulses, shown in Figure 3-6 demonstrates
interesting features of the signal behavior of the slice profiles and shows differences between
both the symmetric and the asymmetric pulses, as well as between the different levels of
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spoiling. First, a drop in signal is seen for composite pulses. The origin of this
difference is shown in the slice signal profile from the sinc pulse (Figure 3-7). The profile
contains a non-trivial region with flip angles below the nominal flip angle. In a short TR, T1weighted sequence, these components can provide a large fraction of the signal within the slice
(30). Effects become more prominent as T1 increases. However, in the composite pulse the
transition regions have a large phase gradient and their contribution is substantially reduced,
producing a smaller overall signal.

Figure 3-6 Theoretical signal as a function of sideband width.
For all of the pulses, a gradual increase of the signal level is found with increasing
sideband width due to imperfect spoiling of the signal. The profiles produced by the
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symmetric pulses are considerably more stable with changes in the sideband
width than those produced by the asymmetric.
When varying the width of the composite pulses, there is an approximately linear drift
in the signal with the width of the saturation bands. The signal change over the entire width is
given in Table 3-1, calculated as the difference of maximum and minimum of signal values for
each pulse, normalized to the signal produced with ω2/ ω1 = 3. The symmetric pulses
demonstrated greater stability with changes in width than the asymmetric pulses, drifting in
signal by much less over the range of widths considered, indicating that they will likely provide
better spoiling of out-of-slice signals and that it is more suitable for in vivo imaging. These
figures assume a homogenous phantom and do not account for differences in spoiling of
inhomogeneous structures out of the slice.

Asymmetric

Full Relaxation

Short T1

Medium T1

Long T1

8%

15%

17%

18%

2%

12%

15%

15%

2%

2%

3%

2%

2%

3%

4%

4%

α=1
Asymmetric
α=2
Symmetric
α=1
Symmetric
α=2
Table 3-1 Range of signals generated by the RF pulse over the sideband widths
considered.
Values are the difference in the maximum and minimum signal, normalized to the median
signal
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Figure 3-7 Slice profile of a sinc pulse.
(a) shows the flip angle slice profile generated by a sinc pulse, while (b) shows the signal
generated by each point along the slice. The horns are due to the low flip angle
components of the slice profile. As the specified flip angle is above the Ernst angle for the
simulation parameters, the region with greatest signal contribution is outside of the
central region of the slice. (c) shows the cumulative integral of the signal produced by the
sinc pulse. (d) shows the cumulative signal produced by the pulse width a saturation
width of 2 mm and α = 2. With the composite pulse, signal from the periphery is spoiled
and has a relatively small contribution. For the sinc pulse, the transition region
contributes a large fraction of the total signal.
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3.5 Measured slice profiles
3.5.1 Methods
All data in this and later sections were acquired on a Biospec 4.7T small animal MR
scanner (Bruker Biospin MRI, Billerica, MA) using the Paravision 4.0 operating system. The
pulses that had been simulated were implemented on the scanner and slice profiles were
measured to confirm the slice profile simulations experimentally. Excitation was performed
with the RF pulse being tested, followed by nonselective 90° and 180° pulses, providing a
measurement of the residual longitudinal magnetization. Acquisition parameters were: TE =
12.4 ms, TR = 4000 ms, matrix size = 256, FOV = 3 cm, receiver bandwidth = 85 kHz, flip
angle = 30°. The pulse duration was 1 ms, yielding bandwidths of 6210 Hz for coherent band,
corresponding to a coherent region width of 2.2 mm and sideband widths from 2.2 mm to 11
mm were used. Measurements were performed in a 6 cm long, 4.7 mm inner diameter (ID)
water phantom doped with 0.5 mM gadopentetate dimeglumine (nominal T1 = 400 ms).
Measurements were made using S116 gradients and a 72 mm ID birdcage coil (Bruker
BioSpin, Billerica, MA) to minimize effects of RF coil inhomogeneity on the acquisition. The
ripple in the slice profile was calculated as before.
The transverse magnetization was measured by excitation, followed by a hard 180°
refocusing pulse. Only the phase was plotted; the measurement of the amplitude was unreliable
because, unlike the simulations, physical measurements are necessarily an integral over a finite
spatial region, which would lead to signal dephasing. Acquisition parameters were the same in
the longitudinal and transverse magnetization measurements. The same phantom and hardware
were used as in the measurement of saturation profiles.
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3.5.2 Results
The measured slice profiles demonstrate good reproduction of the RF pulse. Magnitude
profiles with sideband-to-center ratios of 1, 3, and 5 are shown in Figure 3-8 and Figure 3-9,
while the phases are shown in Figure 3-10 and Figure 3-11. As with the simulations, some
artifacts are visible at the transition between the coherent and the incoherent regions of the slice
profile, however the shape of the slice profiles matches well with the calculated values. As
before, the artifact at the transition is larger for the profile with the greater phase gradient. The
standard deviation of the flip angle in the saturation region remained under 1 degree, which
includes variations from noise. The mean flip angle produced by the asymmetric pulse with a
width of 5 mm and a phase gradient of 2π/mm was 28.1º and 29.0º for the 4π/mm pulse. The
symmetric pulse produced slightly more accurate flip angles of 29.0º and 29.6º, respectively.
These measurements indicate that the pulse is produced as desired by the scanner and that the
desired phase behavior is present.
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Figure 3-8 Measured saturation profiles from the asymmetric pulses.
The profiles all display flat saturation regions, although the more heavily spoiled profiles
show the same Gibbs artifact which appeared in the simulations.
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Figure 3-9 Measured saturation profiles from the symmetric pulses.
The profiles produced by the symmetric pulses show similar behavior to those generated
by the asymmetric pulses. The width of the saturation region increases as desired, and is
the same for pulses with both degrees of spoiling.
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Figure 3-10 Measured transverse profile phases from the asymmetric pulses.
The phase profiles from the asymmetric pulses display the desired combination of
coherent and spoiled regions. The linear phase gradient continues past the desired
excited width due to the sidelobes of the RF pulses that have a meaningful phase but low
amplitude. Slightly more ripple is noticed in the phase profile of the more heavily spoiled
profiles, resulting from the greater Gibbs ringing artifact. Shaded regions indicate
boundaries of the primary excited regions.
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Figure 3-11 Measured transverse profile phases from the symmetric pulses.
As with the asymmetric pulses, the symmetric pulses produce the desired phase behavior.

3.6 Numerical simulations of flow
3.6.1 Methods
Simulations were also performed to investigate the approach of flowing spins to steady
state when excited with the proposed RF pulse. A set of discrete spins were used, which
moved linearly through the excitation region with time. A train of RF pulses that affected the
moving spins was simulated via the Bloch equations, and the signal produced by the spins at
each spatial point was calculated over the entire excitation region. The transverse
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magnetization after each RF pulse was used to construct the signal profile across the
slice. Simulation parameters were: TR = 40 ms, flip angle = 30º, T1 = 1800 ms, gradient
strength = 140 kHz. Flow rates from 1 mm/s to 20 mm/s were tested and a pulse with α = 2 and
ω2/ω1 = 9 that produced a slice thickness of 1 mm was used.

3.6.2 Results
The numerical simulations of flow produced signal profiles along the slice direction,
shown in Figure 3-12. The profiles demonstrate that the magnetization reaches its steady state
value before arriving at the coherent portion of the slice for velocities of up to 10 mm/s, with
the combination of flip angle and TR that were tested. This velocity is somewhat less than
average velocities of 23 cm/s which have been reported in the aortas of mice (87), however, it
must be considered that linear velocity in the heart will be slower because the ventricle is larger
than the aorta and that the width of the saturation region is amplified by tortuous path blood
must travel before entering the ventricle. More rapid flows may prevent spins from reaching
steady state before reaching the coherent center, resulting in incomplete suppression. A
cumulative signal profile for the same three velocities is shown in Figure 3-13. Simulations
indicate that the use of this pulse is able to improve the sensitivity of flow-affected
measurements, but testing in realistic applications is warranted.
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Figure 3-12 Signal profile in the presence of flow.
(a) The signal profile along the slice is shown for a spatial presaturation pulse at several
velocities. Flows below 10 mm/s are fully in steady state by the time they reach the center
of the slice for this protocol. More rapid flows are not in steady state and will have a
reduced sensitivity to contrast related signal changes. (b) The signal profile in the
absence of flow is shown.
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Figure 3-13 Cumulative signal of the profile generated by RF pulse in the presence of
flow.
The signal from the flow-related peak, although large in magnitude, is attenuated by the
incoherence of the sidebands. The most rapid flow, where spins have not reached steady
state prior to entering the coherent portion of the slice, displays considerably flow-related
hyperintensity. Some residual signal, constituting up to 30% of the total signal, remains
when flow travels in a linear path. A greater degree of signal spoiling would reduce this
effect. No amount of increase in the width of the saturation bands will remove this
spoiling because it represents the signal requiring a distance to reach steady state which is
long compared to the spoiling, but not necessary the saturation width.

3.7 Phantom measurements of flow
3.7.1 Methods
The ability of the RF pulse to suppress enhancement due to linear flow was tested in
phantom. A silicone catheter was embedded within a bovine gel phantom (nominal T1 of gel
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was 700 ms, nominal T1 of the water in the catheter was 3000 ms). Flow was
introduced in the catheter using a power injector (Harvard Apparatus, Boston, MA) at several
rates. Composite RF pulses with α = 1 and 2 and ω2/ω1 = 1 to 5 were used for both symmetric
and asymmetric pulses. For RF pulse, spoiled gradient echo images were acquired of the
phantom with flow for 1 minute, followed by 30 seconds without flow. No dummy scans were
acquired, but the initial frame after the injector was started was not included in signal averaging
to account for transitory signal states. Acquisition parameters were: TE = 2.75 ms, TR = 20
ms, flip angle = 25°, matrix size = 256x192, FOV = 4.1 x 3.1cm, receiver bandwidth = 80 kHz,
pulse width = 1 ms, slice thickness = 1 mm. Flow rates ranged from 0.05 mL/min (average
linear velocity of 0.6 mm/s) to 1 mL/min (12 mm/s). The signal for each pulse with and
without flow was measured in an ROI drawn around the interior of the catheter. The flow
related enhancement was calculated as the percent increase in the signal amplitude due to flow.
Additionally, a region of interest was drawn in the gelatin at the center of the phantom and the
mean signal within that ROI calculated for all pulses used. Measurements were made with
BG6 gradients and a 35 mm ID birdcage coil. The choice of the smallest available birdcage
was to maximize the SNR available.

3.7.2 Results
The RF pulse effectively suppressed flow enhancement in phantom. A 5 mm saturation
width reduced the signal of flowing spins to slightly less than that of stationary spins for all but
the flow of 1 mL/min, as illustrated in Figure 3-14, indicating effective flow suppression.
Increasing the phase gradient of the spoiled region from 2π/mm (Figure 3-15ac) to 4π/mm
(Figure 3-15bd) provided slightly greater reduction in flow enhancement for most velocities,
due to better suppression of the signal at the edges of the slice, although exceptions are noted.
The symmetric pulse was comparable to the asymmetric pulse in the effectiveness of reducing
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inflow enhancement, although the stability of the signal in the gel and of the baseline
signal was considerably better with the symmetric pulse than with the asymmetric pulse. The
CV of the signal in the gel (Figure 3-16) with the asymmetric pulses were 41% and 23% for α =
1 and α = 2, respectively, while the symmetric pulses each had a CV of 4%. The fluctuations in
the baseline signal of the tap water were similarly superior with the symmetric pulse: 8% and
7% vs. 18% and 13%. The signal change with sideband width is not the generally linear
behavior observed in the simulations, although the stability advantages of the symmetric pulse
are still present. Deviations from linear behavior may be the result of imperfections in the
phantom, or in the differences between the pulse as idealized and as actually produced. We
observe the decrease in signal relative to the sinc pulse of 40%, which is comparable to the
signal decreases of 45-55% that were found in simulations.
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Figure 3-14 Images of the flow phantom acquired during 1 mL/min flow.
The signal of the flowing water inside the catheter fades away as the width of the sideband
increases and the signal enhancement artifact is reduced in strength. The inset shows a
magnified view of the catheter; signal was measured on the interior of the catheter and
contained only water. Instability with sideband width in the signal from the asymmetric
pulse is observable in the surrounding gels.
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Figure 3-15 Plot of the signals in the catheter during flow.
The percent signal increase in the presence of different rates of flow, relative to the
baseline signal, is shown for two different choices of the sideband phase gradient (a vs. b
and c vs. d), as well as for asymmetric vs. symmetric profiles (a and b vs. c and d). The
composite RF pulse provides effective flow suppression across a wide range of flows.
Volumetric flows are specified to avoid inconsistencies associated with non-plug flows.
The presence of non-plug flow in measured data makes direct comparison to simulations
difficult to perform meaningfully.
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Figure 3-16 Signal of stationary structures in the phantom.
The stability of the signal of stationary structures in the phantom is shown is shown for
two different choices of the sideband phase gradient (a vs. b and c vs. d), as well as for
asymmetric vs. symmetric profiles (a and b vs. c and d). More stable behavior is observed
with the use of the symmetric pulse, as well as the signal decrease relative to a sinc pulse,
as was found in simulations.

3.8 In vivo measurements
All experiments and procedures, in this and later sections, were approved by our
Institutional Animal Care and Use Committee, which is accredited by the Association for the
Assessment and Accreditation of Laboratory Animal Care International. Respiratory
monitoring of subjects was performed (Model 1025 Monitoring & Gating System, Small
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Animal Intruments, Inc., Stony Brook, NY) and animals were kept at respiratory rates
of 20-30 breaths per minute. Constant temperature was maintained with a water-heating and
recirculation system.

3.8.1 Methods
3.8.1.1 Heart and vessel images
To test the ability of the pulse to perform flow suppression in vivo, short axis images of
the heart were acquired using with a spoiled gradient echo sequence. Cardiac motion artifacts
were suppressed by averaging. Acquisition parameters were: TE = 1.7 ms, TR = 40 ms, matrix
size = 128x128, FOV = 3x3 cm, receiver bandwidth = 80 kHz, number of averages = 20, flip
angle = 35°, pulse duration = 1 ms, slice thickness = 1 mm. Symmetric and asymmetric
composite RF pulses with α = 1 and 2 and ω2/ω1 = 1 to 5 were used, as well as a sinc pulse.
ROIs were drawn on the interior of the left ventricle and on the fat in the shoulder to measure
the signal change with the width of the saturation region.
Additional in vivo measurements were performed using the symmetric pulse with α = 2
for wider saturation bandwidths and at two anatomic locations. Comparisons were made
between structures with linear and tortuous flow to investigate the possibility of signal bias due
to incomplete spoiling of the initial signal peak. Separately acquired short axis images of the
heart and an abdomen, in which the inferior vena cava (IVC) was visible, were acquired using a
spoiled gradient echo sequence in separate acquisitions. Acquisition parameters were: TE =
1.7 ms, TR = 40 ms, matrix size = 128x128, FOV = 3x3 cm, receiver bandwidth = 80 kHz,
number of averages = 20, flip angle = 30°, pulse duration = 1 ms, slice thickness = 1 mm.
Composite RF pulses with α = 2 and ω2/ω1 = 1 to 7 were used, as was a sinc pulse. The signal
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in each image was normalized to the signal of muscle from each slice. Average
signal intensities of the blood within the left ventricle and the IVC were measured.
3.8.1.2 VIF measurement
The change in sensitivity to the presence of contrast agent with and without the
presaturation was demonstrated by interleaving VIF acquisition in the heart with a flow
suppressed pulse with measurements made with a sinc pulse in the same anatomy. Baseline T1
measurements were performed using a variable flip angle protocol with a spoiled gradient echo
sequence. Acquisition parameters common to all images were: TE = 1.7ms, TR = 40 ms,
matrix size = 128x96, FOV = 3x3 cm, slice thickness = 1 mm, receive bandwidth = 80 kHz,
number of averages = 10. For the composite RF pulse, which was symmetric, the saturation
width was 5 mm and α = 2. The flip angles used for the T1 measurement were 10º, 20º, 30º,
and 40º. The T1 was calculated by fitting the measured signal to the signal equation with a
nonlinear least-squares fit (31). After T1 measurement, a 300 µL bolus of 83 mmol contrast
agent (gadopentetate dimeglumine) was injected through a tail vein catheter. Acquisition
parameters were the same as the variable flip angle measurement, but only a flip angle of 30º
was used. Dynamic images were acquired beginning approximately 30 seconds after injection.
Image acquisition with each pulse was interleaved.

3.8.2 Results
3.8.2.1 Heart and vessel images
In the first set of anatomic images where symmetric and asymmetric pulses were
compared, as the width of the sideband increases, the signal of the blood in the ventricle
decreases to be similar to that of the surrounding myocardium, again indicating that the flow
enhancement effect is being suppressed, as shown in the progression of images in Figure 3-17.
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Images with the 2π/mm show considerable banding artifacts that are not visible in the
images with the larger phase gradient. This appears to be due to better spoiling of changes in
the out-of-slice signal with the larger phase gradient. It was not clear if the signal in the left
ventricle had stabilized, so supplementary measurements were performed with wider saturation
regions, and are presented at the end of this section.

Figure 3-17 Anatomical images acquired with the flow suppressive pulse.
Signal in the blood is, like signal in the catheter, shown to decrease with the increasing
width of the sideband. Signal fluctuations are again visible with the asymmetric pulse,
but not with the symmetric pulse, which effectively suppresses flow without artifacts.
Arrows indicate where signal was measured.
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The symmetric pulse produces images with a considerable improvement in
the stability of the normal tissue signal as compared to the asymmetric pulse (Figure 3-18). For
the 2π/mm asymmetric pulse, the coefficient of variation of the ROI in normal tissue over the
width of the sideband is 21.7%, while for the 4π/mm asymmetric pulse it is 15.0%. The
coefficients of variation for the 2π and 4π symmetric pulses the coefficients of variation are
5.7% and 3.5%, respectively. This is again consistent with the simulations and the phantom
data.

Figure 3-18 Plots of in vivo signal in the left ventricle and in solid tissue as the width of
the presaturation region is increased.
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For all pulses, use of the flow suppressive pulse reduces the amount of flow
enhancement. Consistent with previous observations, the symmetric pulses produce more
stable signal levels in the stationary tissue.
Because it was inconclusive if the 5 mm width was sufficient to minimize flow
enhancement, another set of images were acquired using only the symmetric pulse with α = 2.
In this set of images, the signal of the blood in the ventricle and IVC again decreases with the
sideband width in vivo, shown in Figure 3-19, indicating a decrease in flow-related
enhancement. The signal from fat was stable as the width was varied (4% CV) while the
structures with flowing blood converged to a stable signal after 5 mm of presaturation. The
ultimate stability of the signal is a strong indicator that spins are in steady state by the time they
reach the coherent region. The bias suggested in simulations with high flow velocity may also
be manifest in inferior vena cava and the other veins in the cardiac slice. These vessels remain
hyperintense even when the blood in the heart has reached a highly saturated state, which is
possible evidence for residual flow enhancement.
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Figure 3-19 Comparison of images acquired at the IVC with the heart.
Images show the IVC and heart of a mouse acquired with a sinc pulse (a) and the flow
suppressive pulse over multiple sideband widths (b-d). Flow suppression is visible even at
narrow bandwidths and a 5mm suppression band is sufficient to suppress inflow
enhancement even within the heart at a TR of 40 ms. The signal from fat is stable as the
sidebands are changed, indicating that the signal from those regions is effectively
suppressed, as shown in part (e). The geometry of the cardiac slice, shown in (f), shows
that the saturation region covers the majority of the lungs and heart, indicating that the
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pulse may be particularly suited to flow suppression in the heart, due to the
extended period of time blood stays within the saturation region in this case.
3.8.2.2 VIF measurement
The measured T1 values of flowing blood differed substantially between the
conventional sinc pulse and the flow suppressive pulse (Figure 3-20). The former gave 196 ms,
while the later gave a measurement of 1739 ms. The value measured with flow suppression is
consistent with the values reported by Pickup, et al. of 1780±60 ms for mouse blood at 4.7T
(10), another indication that the applied suppression sufficiently eliminates inflow enhancement
in vivo.
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Figure 3-20 T1 mapping signal curves.
The signal measured with the non-flow suppressive sinc pulse continues to increase with
flip angle even to a fairly large angle, characteristic of a short T1 tissue. This is not the
case of the signal measured with the flow suppressive pulse.
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Figure 3-21 Signal time courses measured in the heart with conventional and flow
suppressive excitation.
The baseline (pre-injection) signals are shown as horizontal lines. The baseline signal for
the sinc pulse is considerably larger than that of the flow suppressive pulse, due to the
short apparent T1 without flow suppression. Because of this, the same amount of contrast
agent causes a much smaller signal increase when using the conventional RF pulse.
Comparison of the post-injection signal time courses of the two pulses demonstrates
that the loss of sensitivity caused by inflow enhancement (Figure 3-21) with conventional
excitation is mitigated by the composite RF pulse. Although the sinc pulse produces a larger
baseline signal due to the flow enhancement, the introduction of contrast agent produces only a
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25% increase in the signal, while that same contrast agent concentration showed a
450% increase in signal with flow suppression.

3.9 Discussion
Flow suppression is a key component of the planned VIF measurement in the heart.
This is well demonstrated by comparing the two VIFs measured in the heart, where much of the
structure of the VIF is lost without flow suppression. However, the RF pulse developed here
allows for effective flow suppression without requiring additional time in the pulse sequence.
The coherent region at the profile center is the source of the signal, and maximum
sensitivity to contrast agent is achieved when spins are at steady state there. Imperfect spoiling
may result if the applied phase gradient in the saturation regions is insufficiently sharp, causing
residual flow enhancement for linear flow. Residual signal will be maximized if the flow
travels in a straight line perpendicular to the slice. This effect was prominent when comparing
signal in the IVC, a structure with linear blood flow, to the left ventricle, where blood must
pass through the lungs and other three cardiac chambers before entering. The tortuous path
blood takes through the saturation region near the heart may make the pulse particularly
suitable for use in this region. The signal from the IVC was consistently higher than the signal
measured in the left ventricle, with both signals were normalized to muscle. The veins in the
thoracic slice containing the heart remained hyperintense even with relatively wide saturation
regions.
Two types of waveforms were studied: both symmetric and asymmetric. They differ in
that they produce slice profiles with different spatial dependence of the phase in the slice
profiles. The symmetric pulse has a peak power requirement which is half that of the
asymmetric pulse and produces apparently more effective spoiling in vivo, as well as providing
a more stable signal. For this reason, the symmetric pulse was preferred for VIF measurement.
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Two levels of spoiling were also tested. Greater degrees of spoiling were not
tested due to a desire to match the pulse duration to that achieved with a conventional sinc
pulse used for imaging. Increasing the phase gradient further would require extending the
duration of the RF pulse. Increasing the phase gradient without lengthening the RF pulse
would cause the main lobe of the suppression component to be truncated, resulting in severe
slice profile artifacts. However, the stability of the signal in normal tissue indicates that image
quality can be maintained with the timings used.
The pulses used in this experiment all had a fixed duration of one millisecond and a
coherent slice thickness of one millimeter. With these parameters fixed, the design of the RF
pulse was limited in two respects. As previously mentioned, the amount of phase change is
limited by the shifting of the centers of the component pulses. The maximum width of the
sidebands which can be generated is limited by the available RF power of the system because
the narrower RF component pulses that generate wider suppression bands require greater
amplitude to produce the same tip angle. These constraints were able to be satisfied on the
available system, however, different systems have somewhat different limitations, and some
modification of the duration of the RF pulse may be required.
With the development of this pulse, we have provided an efficient way for bringing
blood into the appropriate steady state magnetization prior to its arrival in the left ventricle.
However, while this addresses one limitation of VIF measurement, the temporal resolution
which could be attained for the measurement is still limited by the need to acquire k-space for
the measurement. This difficulty will be addressed in the next section.
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4 Specific Aim 2 – Constrained reconstruction analysis
for rapid VIF sampling
4.1 Introduction
High temporal resolution is desired for VIF sampling to achieve accurate or
reproducible measurements of pharmacokinetic parameters. A frequently cited target sampling
rate is taken from a simulation study by Henderson, which found that a sampling rate of at least
once per second is required, in humans, to obtain uncertainty bounds of 10% on all three of the
parameters in the extended Toft’s model for parameter values typical of breast cancer (39), and
other researchers have also found similarly demanding requirements (68). No corresponding
estimate of the required temporal resolution for small animal DCE-MRI has been published. It
is expected to be higher due to the faster VIF dynamics which occur in mice, although the
necessary temporal resolution is not obvious because tissue permeability does not increase
proportionally in mice. Additionally, sampling in a short time frame reduces motion-related
inconsistencies and prevents the potentially large errors which can occur due to mismatches
between the k-space acquisition pattern and the bolus arrival (70).
However, achieving a temporal resolution of even one second with sufficient slice or
volume coverage is challenging with conventional acquisition techniques. As will be discussed
in the next section, most constrained reconstruction techniques are able to produce acceleration
factors of about eight. Reconstruction of a full image with a full complement of anatomical
detail from highly undersampled data is a difficult problem. However, simplification is
possible when the spatial details are not of interest and the objective is simply the mean signal
in an ROI. We have proposed an algorithm, called cardiac anatomy constrained, temporally
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unrestricted sampling, or CACTUS, to perform highly constrained reconstruction
which is capable of extracting the desired information from as little as a single projection.

4.2 Techniques for acquisition acceleration
Achieving high temporal resolution can be difficult in MRI, and numerous methods
have been proposed to exploit redundancies and correlations in MR data in order to reduce the
data required for image reconstruction. Many types of constraints and assumptions have been
exploited, ranging from strategic undersampling of dynamic data (88-90), or sparsity
assumptions (91-97), to modeling the image as generalized series (98-103). Parallel
imaging (104) which relies upon using multiple receive coils to introduce additional encoding
may also be used to accelerated image acquisition.
Generalized series type approaches, such as reduced-encoding imaging with
generalized-series reconstruction (RIGR), were originally put forth by Liang (99), although
many other investigators have applied the basic approach in which a dynamically acquired,
undersampled, portion of k-space is extrapolated to be most consistent with a reference image
(105). Some variations also use multiple reference images, such as ones acquired before and
after administration of contrast, which leads to more accurate quantification and more reliable
results (106). This approach, called two-reference RIGR (TRIGR), has been tested for DCEMRI purposes. Good results were obtained with 64 and 32 phase encode lines, but at an
acceleration factor of 16 or greater pharmacokinetic parameter maps were rendered
unusable (28). In qualitative imaging situations, such as investigating the motion of the tongue
during speech (105), reasonable results have been achieved with only 8 phase encode lines.
Parallel imaging uses multiple coils with different sensitivity profiles to achieve
acceleration (104). While useful in many applications, the achievable acceleration is limited by
the number of coils used, and dedication of coils to sampling the heart with high acceleration
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consumes receive channels that could be used to improve tissue sampling. While
potentially a viable tradeoff, it is also a costly one because improvements in sampling the VIF
would come at the cost of sampling the tissues of interest.
Highly constrained backprojection (HYPR) was originally designed for magnetic
resonance angiography (MRA) and creates a composite image from a set of undersampled data
and then retrospectively interpolates a high temporal resolution set of images (95). It has the
ability to produce extremely high acceleration factors (~100) for the reconstruction of 3D
sparse data sets. In the presence of enhancing background tissue, as would be encountered in a
DCE-MRI experiment, a modified approach must be used, such as iterative HYPR (I-HYPR)
(96). This modified technique has demonstrated lower acceleration factors, requiring as many
as 32 projections per time frame to reconstruct an image (96).
Compressive sensing is a relatively new technique that achieves high acceleration
factors by using pseudo-random acquisition strategies to effectively transform aliasing artifacts
into noise, which is then eliminated by a non-linear reconstruction (91,93). It relies on the
assumption that there is a sparse representation of the image being reconstructed in some
parameter space; a frequent choice is a wavelet basis. Maximum acceleration is determined by
the level of detail and structure in the image. Specifically, compressive sensing techniques
require 2-5 times as many samples as there are non-zero coefficients in its sparse
representation; even at its extreme limit compressive sensing cannot reconstruct a reasonable
image from fewer than about a dozen k-space lines (93).
Very large acceleration factors have also been achieved with a technique called SLIM
(spectral localization by imaging) (107). It used a reference image to provide a basis for
anatomic segmentation, although the reference was not directly used in the reconstruction.
This allows sifting different spectra from distinct spatial regions. This technique forsakes any
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knowledge of the structure within the regions, but requires minimal data (as few as
two phase encode lines) to sample the structures of interest.
We follow in the approach of SLIM by achieving highly accelerated sampling by using
anatomical constraints. Like HYPR, we are able to retrospectively interpolate high temporal
resolution data from individual projections that compose a complete, low-temporal resolution
acquisition. SLIM processes spectroscopic data, and thus in order to achieve spatial separation
at least two acquisitions with different phase encoding are acquired. We are not interested in
spectroscopic data and in principle only require a single projection. However, preliminary
simulations (§4.5) indicate improved robustness with the use of multiple projections.

4.3 Theory
4.3.1 Derivation
This structure-oriented reconstruction is developed in the context of a radial data
acquisition scheme. Through the projection-slice theorem, a spoke in k-space is related to the
full image by
(Eq. 4.1)
(Eq. 4.2)
where Sk,t is the spoke in k-space at angle θ at time t, F is the one-dimensional Fourier
transform along the spatial dimension, Pt is the projection at angle θ, and the position along the
projection is given by r, R is the Radon transform, and St(x,y) is the signal intensity distribution
in the spatial domain. Solving this system of equations for a full set of projections reconstructs
the image and is the approach used in a conventional algebraic reconstruction technique, where
the image reconstruction equation is expressed as a matrix whose coefficients are determined
by ray-tracing through a grid (108).
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To simplify the system of equations, reducing the number of unknowns and
decreasing the number of projections required, we partition the image into N ROIs, defining the
indicator function for the ith ROI as:
(Eq. 4.3)
We assume that the ROIs enhance smoothly, in the sense that, for a voxel at position x,y
located within the ith partition:
It(x, y) = wi(x,y,t)I0(x, y)

(Eq. 4.4)

where I0 is a reference image of the anatomy and wi(x,y,t) is a smooth contrast modulation
function for the partition that relates the dynamic images to the reference. We can expand this
function as a Taylor series in the spatial dimensions:
(Eq. 4.5)
where xi and yi denote the point around which the Taylor series is evaluated.
Truncating this series reduces the number of coefficients required to describe the
dynamic coefficients. This can be considered a form of modeling the image as a set of partially
separable functions (109). For our purposes, it suffices to keep only the spatially constant term
of the Taylor series
(Eq. 4.6)
This physically corresponds to assuming homogeneous enhancement within the ROI. Spatial
details are not needed for VIF measurement, only the mean signal within the blood in the left
ventricle. Combining the above equations leads to
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(Eq 4.7)

The linearity of the Radon transform allows bringing the spatially constant, temporally varying
value of wi outside of the transformation. This produces a set of linear equations in a number
of unknowns equal only to the number of partitions.
To solve the system of equations, we express the equations as a matrix

(Eq. 4.8)
assuming N segments and recognizing that the signal and Radon transform terms are vectors
with a length equal to the number of readout points. Modifying the algorithm to include
projections at multiple angles is straightforward:

(Eq. 4.9)
where a horizontal line implies concatenation and assuming M projection angles. Denoting the
matrix containing the reference data as A, the measured signal vector as P, and the weighting
coefficient vector was w, we have
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(Eq. 4.10)
Because there is one equation for each point along the readout direction, the set of
equations will be overdetermined. The system of equations may be solved in the least-squares
sense (110) to produce coefficients describing the dynamic behavior of the image. Specifically,
denoting the pseudoinverse of A as A+, we may solve for w:
(Eq 4.11)
An illustration of the relationship between the segmentation, the derived basis functions, and an
an unknown image is shown in Figure 4-1.
It must be noted that the use of this algorithm does not lead to the reconstruction of an
image, but rather to mean signals in an ROI. For our application, we are only concerned with
the mean signal, and the restriction is appropriate.
After the weighting coefficients for the regions of interest have been determined from a
given projection, the signal in that ROI can be estimated

(Eq. 4.12)

where the bar represents spatial averaging.
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Figure 4-1 Schematic representation of the CACTUS algorithm.
An example application of the constrained reconstruction algorithm is diagrammed in the
figure. A reference image is segmented into several distinct structures; these components
of the image can be transformed into basis vectors by numerically calculating the Radon
transform of the image. Then, a single projection can be acquired of the same anatomy
with different contrast (i.e., after the introduction of contrast agent). A least squares fit of
the shapes from the reference image, as described by the basis functions, to the measured
projection, allows for the reconstruction of the unknown images.

4.3.2 Comparison to other techniques
The technique described here shares many common themes with other approaches for
reconstruction from undersampled data, most notably SLIM. Both CACTUS and SLIM use an
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anatomical segmentation to guide interpretation of a very sparse set of phase encode
lines. However, CACTUS has several features which make it more suitable to application in
dynamic imaging.
The original SLIM algorithm used Cartesian phase encoding to spatially separate
signals from different regions, while in this work the Radon transform was used. This
difference does not affect the derivation shown; the equations are valid for any linear
transformation of the data. However, with the Radon transform the projection angle used can
be varied while still obtaining the center of k-space. This allows for the acquisition of fully
encoded images that may be used as references and allows the measurement of a low-temporal
resolution VIF to serve as a reality check on the constrained reconstruction. While it would be
possible to vary the phase encode line used with the Fourier transformation, exclusion of the
central region of k-space from measured projections would potentially compromise the SNR of
the signal curves produced.
A more substantial difference is that CACTUS uses a true reference image to generate
basis functions, unlike SLIM, which uses a uniform image. In the notation used here, this is the
same as assuming that I0(x, y, t) = 1. Using a measured reference image has two effects. One
is that it causes w to be defined relative to the signal in the reference image. A value of 1
corresponds to the same signal as in the reference image, a value of 2 corresponds to the signal
doubling, etc. Changing the reference image redefines w. This is of practical importance if the
reference image is updated during data acquisition.
The second consequence is that, because w describes the voxel-by-voxel scaling of the
image being reconstructed with respect to the reference image, it implicitly accounts for some
forms of variation in the image. Spatially varying, temporally constant multiplicative factors,
such as the background phase of the image, are inherently included in the reference image. For
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example, if two voxels have a background phase that varies by 90°, then signals of 1
and i will become 2 and 2i; which are different absolute changes but the same relative changes.
This approach is expected to provide more resistance to background phase variations than the
assumption of fully homogenous signal that was used in SLIM because susceptibility-related
phase variations across the image can lead to signal fluctuations in tissue when the projection
angle changes. A comparison of reconstruction using both the CACTUS approach to reference
images and the SLIM approach will be performed in §4.13 .
Ideally, uncertainty due to reconstruction errors should be less than the background
noise of the image. Image SNR levels cited for DCE-MRI protocols are on the order of 8 (31)
to 10 (111); this implies that noise and motion-related fluctuations should be no more than 10%
of the signal, and preferably less. We will generally desire 5% uncertainty in this work for
signal estimates to keep reconstruction-related artifacts below the noise level of the image.

4.4 Numerical phantom simulations
4.4.1 Methods
Dynamic enhancement was simulated in a numerical phantom to demonstrate the proofof-principle that the CACTUS algorithm can produce accurate signal measurements even in the
presence of imperfectly homogenously enhancing tissue. The feasibility of the CACTUS
algorithm was tested in a dynamic numerical phantom, shown in Figure 4-2a, containing a
small region that rapidly changes to model the vasculature and several large slowly enhancing
regions that represent normal tissue. Each voxel of the phantom was assigned an independent
T1, KTrans, and ve chosen from a Gaussian distribution with a standard deviation of 25% of the
mean of that parameter for that tissue type. Enhancement was simulated by assuming the twoparameter Tofts model and a biexponential AIF:
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(Eq. 4.13)
with t in minutes and Cp in mmol. Values are taken from Padhani, et al.(112), modified to give
greater differences between tissues (Table 4-1). A radial acquisition was simulated with TR =
40 ms, flip angle = 30°, number of spokes = 384, matrix size = 512 x 512 over a time of 250 s.
Fully encoded images were acquired at a rate of 15.4 s per image; this is not a reasonable
sampling rate for VIF measurement but serves to highlight the temporal resolution achieved by
the constrained reconstruction algorithm. Both filtered backprojection (FBP) and the
constrained reconstruction algorithm were used to measure the mean signal within each ROI.
The reference image used in constrained reconstruction technique was a fully encoded precontrast image and reconstruction was performed on each individual projection. Signals from
both techniques were compared to the true value.
T1

KTrans

ve

Blood

1800 ms

-

-

Myocardium

2100 ms

0.25 min-1

0.2

Muscle

1600 ms

0.125 min-1

0.5

Fat

400 ms

0.05 min-1

0.4

Table 4-1 Parameter values used in the simulation

4.4.2 Results
The numerical simulations of dynamic uptake showed very close agreement between
the true signal means and those calculated through CACTUS; the difference between the true
and the constrained reconstruction signal for any ROI and any time point was 0.8%. The
standard deviation of signal in the ROIs ranged from 14% to 25% of the mean. Measurement
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of signals from fully encoded filtered backprojection images, while suitable for the
slower enhancing tissues, was not able to accurately measure the peak of the simulated VIF and
significantly altered the initial rise of the signal and caused a loss of the peak signal, as shown
in Figure 4-2b. Even though the heterogeneity in signal across each ROI was substantial, the
constrained reconstruction approach provided an accurate measurement of the signal mean.
The presence of T1 heterogeneities prevents the spatially averaged signal from being a
representation of the true concentration level. For this reason, calculations were not undertaken
to test whether mean values would lead to mean estimates of the original pharmacokinetic
parameters. Because blood is a fluid that is continually mixed in vivo, heterogeneous T1
behavior is not anticipated to present a problem for VIF measurement within the left ventricle.

Figure 4-2 Numerical simulation of dynamic uptake.
The simulated enhancement time courses in the four tissues are plotted. In all cases, there
is excellent agreement between the constrained reconstruction and the true value of the
signal; the true signal and constrained reconstruction are visually instinguishable. The
VIF (b) shows distortion of the initial peak as a result of the prolonged sampling required,
although it is able to characterize the signal of the solid tissues well.
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4.5 Simulation of segmentation errors
CACTUS relies upon an anatomic segmentation. However, segmentation based on
anatomical features may not produce an accurate functional representation of the image.
Therefore, the impact of segmentation errors on measurements produced by the algorithm was
investigated via simulation. Although a theoretical description of all possible segmentation
errors is beyond the scope of this work, it is possible to consider example cases which illustrate
the effects of errors and provide guidance as to their effects.
The effects of segmentation errors can be quantified by assuming that there is a true
segmentation that describes the image dynamics. In this case, there is a true segmentation .
A second segmentation that contains some error is given by . Both segmentations can be
used to produce a system matrix from a reference image I0:

The true segmentation accurately describes the changes to the image. As a result, given
contrast weighting terms, the measured projection can be constructed:
(Eq. 4.14)
For the flawed segmentation, this does not hold. However, it is still possible is to construct an
imperfect estimate of the weighting functions given a projection:
(Eq. 4.15)
Combining these two matrices allows describing errors in segmentation in terms of errors in
contrast change:
(Eq. 4.16)
This same relationships holds when multiple projections are used in the reconstruction, with the
final expression being identical (although the form of

and

differ).
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Although the most natural example of a segmentation error is a gross failure
to identify anatomy, the concept is more general. Other possible errors would include large
regions of soft tissue fed by different branches of the vasculature; different regions would show
different dynamics, even if grouped as one tissue in the segmentation.

4.5.1 Numerical phantom
4.5.1.1 Methods
We first consider a three-region simulation with a simple geometry. A numerical
phantom, shown in Figure 4-3, was created with a large (120 pixel radius) circular “body” ROI,
in which were embedded two smaller ROIs. One of the two represented an identified “target”
ROI (radius of 24 pixels), while the other represented an occult ROI (variable radius) that is not
segmented out of the body.

The occult ROI represents some feature which has not been

correctly identified. In these simulations we investigate the effects that such a segmentation
error has on the signal measured in the other regions.

Background
Occ

Target

Het
Figure 4-3 Numerical phantom from the occult heterogeneity simulations.
The three structures in the simulation are shown, consisting of a background region, a
known structure, and an occult structure.
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Acquisition and reconstruction from two projections was modeled by taking
the Radon transform of the phantom, and the matrix

was calculated for all possible pairs of

projection angles (sampled in 1° steps). The equations produced had the form:
(Eq. 4.17)

and

where
,

, and

are the contaminated weighting coefficients of the body and target ROIs,
are the true scaling coefficients of the three ROIs, and

and

are geometry dependent coefficients which describe the leakage of the signal from the
occult ROI into the others. These parameters are dimensionless measures of a partial volumelike effect that causes the signal between different ROIs to mix. Understanding how

and

change with the acquisition geometry allows choosing a geometry that minimizes the
impact of segmentation errors on measurements made using the constrained reconstruction
algorithm.
Three scenarios were considered for the orientation of the projections with the anatomy.
In the first case, one projection was oriented to provide the maximum overlap between the
target ROI and the occult ROI, while the orientation of the other projection varied. In the
second case, one projection was fixed at the minimum overlap of the two ROIs while the other
one was varied. In the last case, the effects of the separation angle between the two projections
was investigated in terms of the maximum amplitude of
orientation of the acquisition geometry and the phantom.

and

for any relative
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4.5.1.2 Results
The numerical simulations indicate that the effects of focal segmentation errors can be
reduced, although not completely eliminated, through the use of multiple projections.
Considering the case where one projection is fixed to maximally overlap the target ROI and the
occult ROI (one projection fixed at 90°), a second projection can reduce the contamination
artifact by a factor of ~2.7 when widely separated (Figure 4-4a), at the expense of introducing
some contamination (up to 3%) into the surrounding region (Figure 4-4d). However, no choice
of projection angles completely eliminates the contamination artifact. Fixing one projection at
minimum overlap (0°) produces smaller overall errors, although they are not completely
eliminated, except at one particular combination (Figure 4-4be).
However, this discussion relies upon knowing the location of the supposedly unknown
object. More relevant to protocol design is to apply a criteria of minimizing the maximum
error. Figure 4-4cf illustrates that for any possible orientation of the projections, even a
modestly wide separation angle of 40º minimizes the worst case value of

and

, and

that using a wider angle does not cause harm.
These simulations represent the effects of segmentation errors and do not model the
effects of noise. Because the primary geometry being considered is the relative orientation of
the target and occult ROI, the separation width and angle of the two bodies relative to the body
ROI should not strongly affect the curves.
Because of the strong dependence of the partial volume contamination on the projection
angle, strong oscillations occurring when the projection angle is varied is an indicator that the
segmentation does not fully describe the behavior of the system. Although it may be possible
to derive a method for identifying segmentation errors from the structure of the oscillations, at
present it remains only a diagnostic marker.
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Figure 4-4 Signal contamination, simulated in the numerical phantom.
Subplot a shows the values of

for with one projection forced to maximally overlap

the target and occult ROIs. Subplot b shows the values when one projection is forced to
minimally overlap the two. Analogously, d and e show values for

. The maximum

value of these parameters for any pair of orientations is given in parts c and f.

4.5.2 In vivo simulation
4.5.2.1 Methods
The same calculations were run in a more complicated and realistic geometry.
Segmentation was performed of a short-axis view of the heart. A disc ROI was placed in the
lung at the level of the heart and its radius was varied from 1 to 5 voxels representing varying
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extents of segmentation error. This segmentation was used as the true segmentation,
and the original segmentation was used as the flawed segmentation. The size of the left
ventricle in this image was approximately a circle with a radius of 9 voxels. Proceeding as in
the previous section,

was calculated for the same combinations of angles.

4.5.2.2 Results
Once again, the error propagation matrices again had a simple form:
(Eq. 4.18)

where wi is the true weighting coefficient of the ith ROI, wLung is the true weighting coefficient
of the lung ROI, and wOcc is the true weighting coefficient of the occult ROI. The contaminated
solutions are denoted with tildes. The symbols ki and kLung represents geometry dependent
coefficients that describe the signal contamination. The segmentation used is shown in Figure
4-5.
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Figure 4-5 Segments generated from the in vivo data.
The anatomic structures identified in the segmentation are identified. RV = right
ventricle, LV = left ventricle, Myo = myocardium
The simulations that are inspired by in vivo anatomical structures show more
complicated behavior than the numerical phantoms (Figure 4-6). The more complicated
anatomy produces more complicated angular dependence of the segmentation artifacts.
Additional large peaks occur even when the separation of the two angles is relatively large.
However, even in this scenario, a separation angle of at least 60° gives some resistance to the
worst possible artifacts.
Based on these simulations, it was decided that a two projection reconstruction would
be used with a separation between consecutive projections of between 60° and 120°.
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Figure 4-6 Signal contamination, simulated with the in vivo data.
The curves from the heterogeneity with radius 5 (abc) have the same structure as those
from the smaller artifact of radius 3 (def), but with lower amplitudes. Colors of the lines
match the ROI segmentation. Although the behavior of the curve is more complex than
those of the numerical phantom, the key point that wide separation of the projection
angles reduces artifacts remains. The unshaded areas in c and f show the region between
separations 60º and 120º where all of the curves are at or near their minima. The curves
for the other size heterogeneities show similar curves, with the magnitude of the
contamination coefficients increasing with larger ROIs.
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4.6 Phantom measurements
4.6.1 Methods
The constrained reconstruction algorithm was tested using a phantom containing four
samples of water doped with contrast agent (gadopentetate dimeglumine; concentrations: 0.8,
0.6, 0.3, and 0.15 mmol, intended to produce T1 values in the range of 200 ms to 1000 ms) in a
bath of tap water. The use of homogeneous samples provides a good test of the algorithm in
the presence of a system which will behave as close as any system will to the homogeneity
approximation. Images were acquired of a phantom at multiple repetition times using a
projection acquisition strategy; acquisition parameters were: TE = 2.5 ms, flip angle = 90º,
acquisition matrix = 256 points over 3.84 cm, number of spokes = 512, receiver bandwidth =
101 kHz. The TRs used were 30, 100, 250, 500, and 1200 ms. Images were reconstructed
using complex filtered backprojection; these images were segmented and the mean signal in the
ROIs was taken as the gold standard. For every TR, all pairs of projections were analyzed
using the constrained reconstruction algorithm for pairs separated by 90°, using the fully
acquired image with TR of 1200 ms as a reference image. The mean and standard deviation of
the ROI signal estimates from all pairs of orthogonal projections were calculated for all ROIs
and flip angles. The segmentation used and a representative FBP image are shown in Figure
4-7.
Additionally, although these measurements were performed for the sake of providing a
test of the algorithm in a phantom with varying levels of contrast, it is possible to derive
estimates of the phantom T1 from this data. T1 estimates for each ROI from both the FBP
images and the estimates produced by the mean constrained reconstruction signal were
calculated by using a non-linear least squares fitting algorithm in Matlab.
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4.6.2 Results
The phantom measurements (given in Table 4-2 and Table 4-3) display good accuracy
of the constrained reconstruction algorithm for the four samples, compared to the desired 5%
criteria. The difference between the mean signal estimate from all projection pairs using the
constrained reconstruction algorithm and the signal from FBP is less than 4% for the samples,
except at the longest TR, where the error reached 4.6% for two of the samples. The accuracy
of the signal in the water bath was slightly worse, with a mean signal difference ranging from
5.6 to 8.4%, which is still acceptable.

Figure 4-7 Phantom and segmentation used in testing the constrained reconstruction.
(a)

The filtered backprojection image from the image with the longest TR. Some

streak artifacts are visible in the image, but they do not severely compromise the results
of the constrained reconstruction algorithm. (b) The segmentation used in the
reconstruction. Letters correspond to those in the tables below. The water bath was
included in the segmentation.
The T1 values (Table 4-4) between the two algorithms again showed fairly good
agreement between the two techniques. The measured values are shorter than anticipated, but
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the study was not designed to measure T1 and the long TR values needed for accurate
quantification of long T1 values were not acquired.

30 ms

100 ms

250 ms

500 ms

1200 ms

A

1.3%

1.3%

1.2%

1.2%

1.5%

B

1.9%

2.5%

2.9%

3.7%

4.6%

C

-1.6%

-0.5%

0.6%

2.3%

4.6%

D

-2.5%

-0.8%

-0.3%

1.2%

3.4%

Water

8.4%

7.2%

6.7%

6.1%

5.6%

Table 4-2 Mean errors of the constrained reconstruction analysis for phantom data
Values are expressed as percent difference from the signal measured with filtered
backprojection
30 ms

100 ms

250 ms

500 ms

1200 ms

A

2.0%

2.0%

2.2%

2.7%

4.5%

B

3.8%

3.9%

4.8%

5.7%

8.6%

C

3.3%

2.3%

2.2%

1.8%

2.6%

D

6.0%

4.9%

4.7%

4.4%

4.9%

Water

4.2%

0.6%

0.4%

0.4%

0.5%

Table 4-3 RMS errors of the constrained reconstruction analysis for phantom data
A

B

C

D

Water

FBP T1

82 ms

126 ms

250 ms

337 ms

587 ms

CACTUS T1

84 ms

127 ms

232 ms

358 ms

599 ms

Table 4-4 T1 values derived from the signal measurements

84

4.7 Static segmentation effects
4.7.1 Methods
Because in vivo application of the algorithm will face challenges due to mismatches
between the segmentation and the anatomy due to cardiac motion, an additional simulation was
performed to investigate the sensitivity of the algorithm to mismatches in segmentation due to
cardiac motion. A dynamic digital phantom was created, and the structures representing the
ventricle and myocardium were constricted to simulate cardiac motion at 17 cardiac phases.
Four segmentation schemes were generated:
1) Segmentation representing the anatomy at end systole
2) Segmentation representing the anatomy at end diastole
3) Segmentation representing the anatomy at 50% of the cardiac cycle
4) Segmentation with a ring-shaped transition ROI between the myocardium and
ventricle containing the region which has both blood and myocardium during
the cardiac cycle
The four segmentations used are shown in Figure 4-8. Synthetic data was generated by taking
projections of the phantom during each cardiac phase at 1° increments. Single projection
CACTUS analysis was performed of each projection with each of the four segmentation
schemes to generate signal curves for each structure in the phantom. No actual changes in the
mean signal of each structure were introduced; signal fluctuations are purely the result of
motion. The mean and standard deviation of the signal in the ventricle were calculated to
compare the effects of motion on the signal measured with each of the four segmentation
schemes.
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4.7.2 Results
Simulations of cardiac motion show that the limitations of a static model of the anatomy
do not excessively compromise the measurement and that the algorithm can produce a
measurement that has a low sensitivity to cardiac motion. Time courses of the apparent signal
from each segmentation are shown in Figure 4-8. Both the error in the mean and the coefficient
of variation were less than 1% when using the additional ring ROI as a dynamic shim (Table
4-5). The other segmentation schemes fared slightly worse: static segmentation based off of
the end systole overestimated the signal by 3%, but fairly precisely (2% coefficient of
variation). The 50% segmentation was accurate, but with greater uncertainty than the shim
segmentation (5% coefficient of variation). The segmentation based on the end diastole
segmentation proved the worst, being both least accurate (4% underestimation) and least
reliable (7% coefficient of variation). All of these uncertainties are small compared to the large
signal changes of up to 400% that occur due to the presence of contrast agent.
Ventricle

Myocardium

Body

Lung

50%

1.00±0.05

0.69±0.05

0.33±0.00

0.10±0.06

End Systole

1.03±0.02

0.75±0.10

0.32±0.01

0.18±0.10

End Diastole

0.97±0.07

0.62±0.05

0.33±0.00

0.09±0.01

Shim

1.00±0.01

0.65±0.02

0.33±0.00

0.08±0.00

True Value

1

0.67

0.33

0.08

Table 4-5 Mean and standard deviation of simulated cardiac signals measured with four
different segmentation schemes.
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Figure 4-8 Simulated signals in heart that vary with segmentation.
The simulated constrained reconstruction waveforms for the four different segmentation
schemes are shown. The segmentation that uses the additional shim ROI stays closest to
the true value of 1 over almost all of the cardiac cycle, with the segmentation based off of
end systole also performing well. Segmentations based on other phases of the cardiac
cycle have large signal changes as a result of the mismatch between the assumed and
actual geometry.
Introducing an additional ROI to allow for compensation of cardiac motion has
substantial benefits in reducing the signal fluctuations due to cardiac motion. In practice, the
easiest segmentation to generate is the average segmentation, because it does not require any
form of gating to produce. An approximation of the shim segmentation can be generated from
the average segmentation by manually segmenting the myocardium and left ventricle. A shim
ROI can be created by using the boundary of the two ROI as its approximate location and
dilating the ROI. Because both the systole and the shim segmentation produced accurate
results, it is reasonable to expect that such an approximation to the shim ROI will also lead to
acceptable results.
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4.8 Filtration of the cardiac signal
4.8.1 Methods
Motion is an obvious challenge for sampling of the VIF in a beating heart. The highest
level of image quality is achieved through the use of prospective or retrospective gating
techniques (113), which allows for reconstruction of images using only single phases of the
cardiac cycle. Self-gating approaches, which introspectively analyze the MR signal, are
preferred because of distortions involving metallic ECG leads (114,115). However, with the
use of the RF pulse for inflow enhancement suppression, the signal from the heart is
substantially lowered and the signal change due to cardiac motion is lessened. We investigated
reduction of signal fluctuations due to cardiac motion in vivo.
A spatially-static projection was repeatedly acquired in a cardiac slice of a mouse with
acquisition parameters: TE = 1.55 ms, TR = 18 ms, matrix size = 256 points over 4 cm, flip
angle = 30º, slice thickness = 1mm. This measurement was using both a sinc pulse for
excitation and a flow suppressive pulse (saturation width = 5 mm). The projection was oriented
to not overlap the left ventricle with the right ventricle or great vessels, which would have
signal fluctuations which were out-of-phase with the signal from the left ventricle. The signal
in a voxel through the largest portion of the left ventricle was measured. Fluctuations in signal
would arise through cardiac and respiratory motion. We investigated three candidate schemes
for reduction of signal fluctuations due to cardiac motion.
1) Identifying local signal maxima
3) A sliding window mean filter, width varied up to 1.2 s
4) A sliding window median filter, width varied up to 1.2 s
The coefficients of variation for signals measured with both pulses after the application of each
filter.
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4.8.2 Results
Filtering of the cardiac signal required the temporal resolution compromise of low-pass
filtration to substantially reduce the fluctuations in the signal. Coefficients of variation for the
maxima filter and two different widths of the sliding window filters are given in Table 4-3.
Time courses for selected filters are shown in Figure 4-9. The signal variation produced by
assorted widths of the mean and median filters is shown in Figure 4-10. We desire an SNR of
12-20 for comparability with the SNR expected in the images of a DCE-MRI protocol, which
can be achieved through filtration. This compromises temporal resolution slightly, but serves
to improve the reliability of non-linear fitting. A wide range of filter widths result in
acceptable levels of signal fluctuations. The optimal trade-off between resolution and noise is
not considered in this work, but two different choices of filter width will be considered in §5.6
and their effects of VIF reproducibility will be considered. A single projection was used
without the application of constrained reconstruction on the basis that if a filter failed to reduce
variation in the simple case with no other sources of motion or error, then it would be unlikely
to provide acceptable results in the more complicated scenario with changing projections. An
additional candidate approach for reducing the variation due to motion that uses the shim ROI
is investigated in §4.11.
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Sinc

Flow Suppressed Data

Raw signal

28%

45%

Maxima filter

21%

45%

1 s mean filter

3%

6%

0.6 s mean filter

4%

8%

1 s median filter

3%

7%

0.6 s median filter

4%

9%

Table 4-6 Signal CVs of the signal under four filtering choices.
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Figure 4-9 Fluctuations in signal due to cardiac motion.
Four different filtering algorithms are shown. Although not an ideal solution because of
the reduction in the temporal resolution of the VIF, the low pass filter is the most effective
technique for reducing signal fluctuations due to cardiac motion.

91

Figure 4-10 Signal CVs produced by mean and median filtration.
At narrow filter widths (<300 ms) the mean filter produces slightly noisier measurements
than the median filter, but this trend reverses itself at the longer filter widths. To obtain
signal fluctuations of the desired magnitude, filter widths of 600 ms to 1000 ms are
needed.

4.9 Retrospective respiratory gating
4.9.1 Methods
Respiratory motion occurs over a longer timescale and is of greater amplitude than
cardiac motion, making it easier to identify. During respiration, the lungs expand, pushing the
liver and diaphragm out of the slice, causing the signal from the liver to decrease. Because the
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liver is explicitly identified during the segmentation process, it is possible to identify
time points corrupted by respiratory motion during contrast agent uptake and remove them,
avoiding erroneous signal fluctuations.
A radial acquisition was performed of a short axis slice traversing the heart to acquire in
vivo data for the sake of testing an algorithm for identifying respiratory motion. Acquisition
parameters were: TE = 1.5 ms, TR = 40 ms, frequency encode = 256 points over 4 cm, number
of spokes = 384, receiver bandwidth = 85 kHz, number of repetitions = 8. Segmentation and
reconstruction was performed using the CACTUS algorithm.
Because of the presence of contrast enhancement in the liver, a simple threshold is
insufficient. To account for changes in the liver signal during acquisition, the signal in the liver
from the FBP image was subtracted from the high temporal resolution liver signal. Then, for
each block of high temporal resolution points corresponding to a single FBP image, the points
with signal above a percentile threshold of were discarded and not included in any fitting or
filtering performed on the VIF. Three threshold levels were investigated: removing the
smallest 20% of points, the smallest 25%, and the smallest 30%.

4.9.2 Results
At the 20% and 25% threshold levels some respirations were not identified from the
liver signal. The use of a 30% threshold for the gating signal identified all of the sharp drops in
the liver signal (Figure 4-11). In the displayed interval, four time points were inadvertently
identified as falsely motion-corrupted at this level, indicating that the 30% level is slightly
conservative. It was preferable to omit a small number of points from the rapidly sampled VIF
than include points with potentially large artifacts, so the more conservative 30% level was
used.
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Figure 4-11 Respiratory triggering derived from the liver.
The trigger signal follows the rises and drops of the liver signal well. A few false negatives
are present (arrows), although the exclusion of a small number of points out of several
thousand is anticipated to be less problematic than including points with large signal
decreases.

4.10 Software implementation
To measure VIFs using CACTUS, values are needed for St, I0, and χi. The former two
quantities can be obtained from MR data; the latter is obtained through manual segmentation of
fully encoded images. This is achieved through a guided segmentation script that is run prior to
CACTUS analysis. First, postprocessing software performed filtered backprojection on the
dynamically acquired projections to produce images with normal temporal resolution. From
those images, the operator is prompted to segment structures found in the cardiac slice: left
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ventricle, myocardium, right ventricle, lungs, great vessels, liver/diaphragm, portal
vein, chest cavity, soft tissue, and the fat around the skin. A two-voxel ring is automatically
generated at the boundary of the ventricle and the myocardium to approximate the shim ROI
used in the previous simulation. The segmentations are used in the constrained reconstruction
algorithm: consecutively acquired pairs of projections are used to produce weighting
coefficients, which are used to scale the signal in the reference image, from which the highly
accelerated signal could be obtained. The FBP image reconstructed from the temporally closest
set of full projection data is used as the reference image. For the protocols used in this work,
this led to VIF updates every 81 ms. Respiratory gating was performed by monitoring the
signal of the liver ROI, which has a substantial drop in its measured signal during respiration.
A 1 s sliding window mean filter was applied to the signal from the left ventricle signal curve
to reduce the effects of cardiac motion and noise.

4.11 Variable flip angle measurements in vivo
We desire precise measurements of the signal in the left ventricle of the heart. Several
components of this aim have focused on techniques to reduce the effects of motion on the
signal measured in the left ventricle. The combination of correction techniques which produces
the least uncertain measurement of the signal will lead to the most reliable measurements with
the constrained reconstruction analysis.

4.11.1 Methods
To test the accuracy of the CACTUS algorithm and assess its sensitivity to cardiac
motion, in vivo measurements in a mouse heart were performed. Multiple flip angles were used
to test the algorithm at different contrasts between blood and tissue. The absence of dynamic
changes due to contrast agent allowed for direct comparison of the constrained reconstruction
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signal in the left ventricle with that from the filtered backprojection images. Radial
acquisitions were performed of a short-axis slice with acquisition parameters: TE = 1.5 ms, TR
= 41 ms, flip angle = 10°, 20°, 30°, and 40°, frequency resolution = 256, frequency FOV = 4
cm, number of spokes = 384, angular increment = 120.5°, receiver bandwidth = 85 kHz,
number of repetitions = 8. The reconstruction algorithm was performed with and without
retrospective respiratory gating and with and without the use of the shim ROI, using the
matching FBP image as the reference. For each reconstruction, the temporal coefficient of
variation of the left ventricular signal from CACTUS was calculated. In addition, a linear least
squares fit was made of the filtered back projection signal to the constrained reconstruction
signal values to assess of the accuracy of the constrained reconstruction algorithm.
In addition to these measurements, an approach for decreasing motion-related signal
fluctuations exists that could not be performed with the previous single-projection study. The
signal in the shim ROI from the constrained analysis will vary with the cardiac cycle. In an
attempt to use this for retrospective gating of the cardiac signal, the signal in the left ventricle at
time points corresponding to local maxima of the signal in the shim ROI was also considered as
a candidate signal. Respiratory gating was used for this measurement. The same analysis was
performed on the resulting left ventricular signal as was performed on the filtered waveforms.

4.11.2 Results
The in vivo cardiac measurements made with the variable flip angle protocol show that
motion-related signal fluctuations can be reduced when both a shim-ROI and respiratory gating
are used, which is consistent with the previous simulations. With both respiratory gating and a
shim ROI, the line of best fit relating the FBP signal to the CACTUS signal had a slope of
1.012, an intercept of -0.002, and an r2 of 0.995, indicating a very strong agreement between
the two (Figure 4-12a). Additionally, the coefficient of variation of the signal, which includes
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variations due to both the cardiac cycle and to changes in the acquisition geometry
with projection angle, was low at all flip angles compared to typically SNR values for DCEMRI studies of 10-12 (111). Measurements made without the corrections for motion showed
increases in the signal variation by up to a factor of 3, indicating that the use of the
retrospective gating and a shim ROI does provide an improvement in resistance to motion.
Retrospective gating with a shim ROI did not produce an acceptable level of signal
fluctuations. The coefficients of variation of the signal ranged from 17% to 50%, which is well
in excess of the desired 5% level of uncertainty. For this reason, the low-pass filter approach
continued to be used in this work.
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Figure 4-12 Stability of the left ventricle signal with and without respiratory gating and
with and without a shim segment.
The measured relationship between the constrained reconstruction signal and the filtered
backprojection signal is shown. Across a wide range of signal levels, the constrained
reconstruction algorithm matches well to the signal from filtered backprojection. The use
of corrective strategies for retrospective gating and the use of a shim ROI together reduce
the fluctuations in the signal level significantly.
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Figure 4-13 Stability of the signal in the left ventricle when performing retrospective
cardiac gating through the shim ROI.
Signal fluctuations are considerably higher when using this approach than with the lowpass filtered signals. For this reason, the signal from the shim ROI was not used as a
technique for gating.
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4.12 VIF accuracy compared to filtered backprojection
4.12.1 Methods
Comparison of the VIF from the left ventricle measured with CACTUS and the
ventricular VIF from FBP was performed to assess the soundness of the constrained
reconstruction approach. A healthy nice mouse was anesthetized using 0.5%-2% isoflurane in
oxygen and placed head-first and supine on an imaging sled. A catheter was inserted into the
tail vein. A radial acquisition was performed of a short axis slice traversing the heart.
Acquisition parameters were: TE = 1.5 ms, TR = 40 ms, frequency encode = 256 points over 4
cm, number of spokes = 384, receiver bandwidth = 85 kHz, number of repetitions = 30. A
bolus of 10 µL of 0.25 M gadopentetate dimeglumine was injected 45 s into the acquisition.
Manual segmentation was performed of the dynamically acquired images.
For each FBP image, the constrained reconstruction algorithm produces 192
corresponding high-temporal resolution samples of the signal in the left ventricle from pairs of
projections. These groups of 192 projections were binned together, and the mean signal of
each bin was calculated and compared to the signal in the FBP image. The RMS difference
between the mean constrained reconstruction signal and the FBP signal was calculated. To
highlight the difference in temporal resolution between the two approaches, the FBP signal was
linearly interpolated in time to match the time points the constrained reconstruction signal was
sampled at and the resulting curve subtracted from the CACTUS signal time course.
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4.12.2 Results
The left ventricle VIF measurements show visibly close agreement between the filtered
backprojection signal and that from the constrained reconstruction approach, shown in Figure
4-14ab. Averaging the signal to decrease the temporal resolution effectively recovers the
original FBP signal (Figure 4-14d), with the RMS difference of the two curves shown was only
4.0%, normalized to the mean of the FBP signal. Comparing the constrained reconstruction
against the interpolated signal (Figure 4-14c) reveals generally small differences between the
two curves except at the initial rise of the curve, indicating both good agreement in slowly
changing regions of the curve and improved temporal resolution with the constrained
reconstruction approach. These results, although qualitative, suggest that measurement with
CACTUS will produce reasonable VIFs with high temporal resolution.
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Figure 4-14 Comparison of constrained reconstruction with filtered backprojection.
The high temporal resolution signal and the conventionally sampled signal from the
filtered backprojection images match well, although as expected the peak of the
constrained reconstruction VIF is higher and the rise steeper than for conventional
sampling.

4.13 Comparison to SLIM
4.13.1 Methods
As previously mentioned, a key advantage of CACTUS over SLIM is that it uses a
measured reference image, allowing for more accurate reconstruction of the dynamic time
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course than when a homogenous reference is used. This assumption was tested by
reconstructing the previous VIF again, this time with the uniform reference (that is,
I0(x, y, t) = 1). Because the uniform reference does not account for variations in the image such
as the background phase, orientation-dependant signal fluctuations may occur. The same
filtering and post-processing was applied to both curves.

4.13.2 Results
CACTUS produced a VIF with fewer oscillations and artifacts than SLIM for this
measurement. Large oscillations are found in the VIF from SLIM, which are very reminiscent
of the effects of segmentation errors found earlier. As discussed, these fluctuations occur from
changes in the mismatch between the measured signal and the reference image that occurs
when the projection angle changes. Additionally, the CACTUS technique lies much closer to
the FBP signal in the slowly varying regions, indicating a more accurate reconstruction of the
signal.
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Figure 4-15 VIF reconstruction with both CACTUS and SLIM.
Measurements made with both constrained reconstruction approaches, as well as the FBP
signal, are shown. CACTUS produces a measurement that is more stable with projection
angle (and thus, time) than SLIM. In addition, the CACTUS signal time course more
closely matches the FBP signal in the slowly varying portion of the VIF.

4.14 Discussion
We have developed a strategy for reduced artifact acquisition of the VIF that relies upon
measurement in the heart, which provides resistance to partial volume effects and an improved
signal to noise ratio due to its large size, and by using a constrained reconstruction approach,
which provides high temporal resolution measurement of the VIF.
The constrained reconstruction algorithm developed and used here relies upon a simple
approximation that allows very large imaging acceleration factors. The homogeneity
assumption, while not necessarily applicable to tumor tissue, or other heterogeneous areas, is
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reasonable for the slowly enhancing soft tissues and muscle found in the chest. This
does not compromise the interpretation of the measurements; the figure of ultimate interest is
the mean signal in the left ventricle. In vivo application of the algorithm demonstrates that it
provides a high temporal resolution measurement of the VIF that is sufficient to capture the
first pass of the contrast agent through the vasculature. Because tumors often display greater
enhancement heterogeneity than normal tissue, care may be needed when disease is present
near the heart. If the tumor does not enhance homogenously, then it may be necessary to
segment the tumor into multiple structures with different dynamics, or to include higher-order
terms of the Taylor series in the reconstruction.
Because all tissue has some level of small-scale structure, such as vasculature, that
would be tedious to manually identify and segment, the segmentation used will necessarily be
an imperfect representation of the dynamic changes in the image. Small structures are likely to
vanish within the image noise and the limited image resolution. Larger structures could be
identified and included in the segmentation.
The numerical simulations indicate that the algorithm can accurately reconstruct highly
undersampled data, even in the presence of spatially incoherent fluctuations. Mismatches
between the segmentation and the actual dynamics of the image present larger challenges, but
these may be minimized through the use of a shim ROI and low pass filtration. Numerical
simulations indicate that the use of a second projection reduces errors associated with imperfect
segmentation. Phantom data shows agreement of the CACTUS measurement with a full
acquisition to within a few percent. This is also found by comparing the CACTUS
measurements to those from FBP, which demonstrates that the constrained approach produces a
measurement which is consistent with the slowly changing component of the VIF, yet which
produces a sharper and more realistic rise of the contrast agent. The temporal resolution
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achieved is faster than the cardiac cycle of a mouse, to the point where it is
reasonable to sacrifice temporal resolution for the sake of motion and noise suppression.

106

5 Specific Aim 3 – In vivo study of VIF repeatability
5.1 Introduction
With methods for both flow suppression and high temporal resolution sampling in
place, whether their combination results in a superior approach for measurement of the vascular
input function in mice can now by tested. The intra-subject and inter-subject variances in VIF
measurement using these techniques in a population of mice were evaluated. The hypothesis of
this work is that intra-subject coefficients of variation will be reduced, but we also anticipate
that a decrease in the inter-subject variation will be achieved.

5.2 Inflow enhancement of cerebral blood vessels
The reproducibility study compared interleaved acquisitions of slices through the heart
and the head and neck region. To fairly compare VIFs measured at each location, inflow
enhancement must be suppressed in the local vessels as well as the heart. However, performing
a full saturation recovery protocol for the head and neck region was infeasible because it would
compromise the temporal resolution of the cardiac slice. The effects of the cardiac slice itself
on the inflow enhancement in the head and neck region was investigated.

5.2.1 Methods
Since the VIFs are to be simultaneously measured in two different slices, it is possible
that the RF pulses that excite the heart, specifically designed to mitigate inflow enhancement,
will introduce some presaturation into the local vessel measurement if the travel time is shorter
than the T1 of the blood. This will reduce the inflow enhancement artifacts found in the local
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blood vessels. We evaluate the signal found in the internal carotid artery and a
cerebral vein in response to the presence of the applied presaturation in the heart.
A 2D gradient echo acquisition was performed of slices through the head and neck of a
healthy nude mouse with the following acquisition parameters: TE = 1.55 ms, TR = 41 ms, flip
angle = 30º, matrix size = 256 x 256, FOV = 4 cm x 4 cm, slice thickness = 1 mm, slice spacing
= 0.5 mm, number of slices = 7, number of averages = 5. In addition, flow suppression was
applied with the following schemes:
1) No flow suppression
2) Varying widths of a flow-suppressive excitation pulse applied in the heart (12
mm offset from the head and neck slices), from 1 to 11 mm, which corresponds
to the geometry intended for typical VIF measurement (i.e., 11 mm corresponds
to 1 mm slice and a pair of 5 mm presaturation regions on each side)
3) A narrower gap (7 mm) between the neck and the flow suppressed area
4) A wider gap (15 mm) between the neck and the flow suppressed area
5) Minimal gap between the neck slices and the suppression region, corresponding
to the use of an additional RF pulse at a 30º flip angle to provide optimal flow
suppression for the local tissues. Widths of flow suppression of up to 22.5 mm
Signal was measured in the internal carotid artery (ICA) and in a vein outside the skull and
normalized to the signal level of that same vessel with the 22.5 mm of flow presaturation. To
account for motion during the course of the examination, the baseline signal measurement
(geometry 1) was repeated before each of geometries 2, 3, 4, and 5.

5.2.2 Results
The signal was found to decrease substantially in the ICA (Figure 5-1a), for which the
presence of an 11 mm presaturation region at the heart produces a 40% drop in signal,
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compared to a 41% signal drop from a 22.5 mm presaturation region applied
adjacent to the slices. Suppression in the veins is less effective with both techniques (Figure
5-1b). The same 11 mm of presaturation decreases venous signal by 8%, which is the same as
the comparable amount using the adjacent presaturation region. With 22.5 mm of presaturation
adjacent to the head and neck slices, the venous signal decreases somewhat more at the full
width to 16%. Suppression is more effective in an artery than in a vein, indicating that the
fairest vessels to choose from comparison are arteries. These results suggest that local vessel
VIF measurement with an 11 mm excitation region in the paired experiment in the heart is a
good approximation of what could be achieved with a dedicated presaturation component of the
pulse sequence.
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Figure 5-1 Indirect flow enhancement suppression of cerebral vessels.
Arterial signal is significantly attenuated by the presence of a dedicated saturation band,
as it is with the indirect suppression applied at the heart. Zero on the width-axis
corresponds to no suppression. The saturation regions applied caudal to the head are
relatively less effective at decreasing venous signal. Signal in brain tissue is stable with
the saturation width applied.

5.3 Animal preparation
Reproducibility studies were performed in healthy nude mice. A total of five animals
were placed under isoflurane anesthesia and given tail vein catheters, which were loaded with
40 µL of heparinized saline followed by 110 µL of 0.25 M gadopentetate dimeglumine.
Animals were kept under anesthesia during the entire acquisition.
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The VIFs were measured in five mice, three of whom were imaged twice to
produce a total of eight reproducibility measurements. Previous comparisons of the variability
between mice and the variability between injections have found that the variability of the same
mice on different days is the same as the variability across mice (63), which means that the
reusing mice does not compromise the independence of the measurements on different days.

5.4 Data acquisition
5.4.1 Methods
After positioning the mouse in the scanner, three-plane localizers were acquired using a
FLASH protocol to permit visualization of the heart. Acquisition parameters were: TE = 1.6
ms, TR = 30 ms, flip angle = 5º, matrix size = 128x128, FOV = 6.4 cm x 6.4 cm, slice thickness
= 1 mm, number of averages = 10. Averaging allowed visualization of the heart without
interference from motion artifacts. These images were used to position the cardiac and
anatomic slices.
Before contrast injection, short axis images were acquired in the heart using a radial
RF-spoiled gradient echo sequence. Acquisition parameters were: TE = 1.55 ms (fat and water
in phase), TR = 41 ms, flip angle = 30º, slice thickness = 1 mm. The acquisition matrix was
256 points over 4 cm with 384 spokes and an angular increment of 120.5º. This angle was used
to disperse projections containing respiratory motion more evenly throughout the acquired
angles than incrementing by 90º. The resulting images were used to verify good visualization
of the heart in the slice.
To account for variations in the preparation of the catheter, low volume (5-10 µL)
injections were performed to clear the saline from the catheter, followed by the acquisition of
another cardiac image. This was repeated until contrast enhancement was observed.
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Afterwards, images were acquired at 15 minute intervals until the signal in the heart
had returned to its baseline value. This guaranteed that the measurement of future injections
would not be influenced by residual contrast agent.
Acquisition of the VIFs in the mice was performed using a spoiled gradient echo
sequence. Acquisition parameters were: TE = 1.55 ms, TR = 41 ms, flip angle = 30º, slice
thickness = 1 mm. One trans-cardiac slice was acquired using a radial acquisition scheme
while seven slices were acquired with Cartesian encoding of the head and neck region. The
acquisition matrix for the Cartesian encoded head and neck slices was 256x96 over a 4 cm x
3.84 cm FOV, providing one sample every 3.9 s. The acquisition matrix for the radial encoded
cardiac slice was 256 points over 4 cm with 384 spokes and an angular increment of 120.5º.
Duration was of the dynamic sequence was 30 repetitions of the radial protocol, corresponding
to 120 repetitions of the Cartesian sequence. A 5 mm presaturation band was applied on each
side of the trans-cardiac slice to suppress inflow enhancement during excitation using the RF
pulse described in Chapter 3. A 10 µL injection of contrast agent was performed with an
injection rate of 0.5 mL/min approximately 75 seconds after the start of the acquisition using a
computer controlled injection system (Harvard Apparatus, Holliston, MA). After the dynamic
acquisition was complete, images were acquired at 15 minute intervals to monitor the clearance
of contrast agent. Once the signal in the left ventricle of the heart had returned to within 5% of
its baseline value, indicating that the contrast agent had cleared from the blood, the dynamic
protocol and injection were repeated. The injection protocol was performed three times per
imaging session.
After data acquisition, VIFs were measured in the heart using the CACTUS analysis
technique. Filtered backprojection was performed to generate anatomic images, from which
manual anatomic segmentation was performed. This segmentation was used to produce a high
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temporal resolution VIF measurement from the left ventricular signal. Further
details on the processing were provided in §4.11. In addition, VIFs were measured in the
conventionally encoded head and neck slices. The same vessel was used for measurements in
all three injections whenever possible. Voxels were manually selected that displayed
prominent signal enhancement and with minimal motion artifacts. All signal measurements
were converted into concentration as described in §2.2using assuming a baseline T1 of 1800 ms
for blood and a contrast agent relaxivity of 4.8 s-1mM-1 for gadopentetate dimeglumine.

5.4.2 Results
Comparison of the VIFs measured with the proposed strategy to those from local blood
vessels reveals that the overall amplitude of the cardiac VIFs is greater. Five of the CACTUS
VIFs display periodic oscillatory artifacts; others display varying levels of noise. The
oscillations are possibly the result of segmentation errors, as suggested in §4.5, although this is
not possible to confirm. Relatively larger fluctuations are visible in the local vessel VIFs,
which result from motion artifacts and noise. Formal reproducibility analysis is presented in
§5.5.

5.5 Curve fitting and statistical analysis
5.5.1 Methods
To allow comparison of the reproducibility of the VIFs measured in the heart to a
conventional local vessel measurement, signal measurements were converted into
concentration(31), and the resulting concentration curves were fit to a biexponential model
(Eq. 5.1)
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where C0 is the amplitude of the slow component of the VIF, α is the relative
amplitude of the fast component, and kslow and kfast are the decay constants of the two VIF
components. Because partial volume and inflow effects tend to affect the entire input function
(58), they affect the amplitude of both terms in the model, as well variations in the injection
amplitude. To partially segregate these artifacts from differences in temporal resolution, the
amplitude of the fast component was defined in a relative manner. With this formulation, the
overall amplitude is most affected by partial volume and flow artifacts, and the relative fast
amplitude is most affected by the temporal resolution. This segregation is imperfect because
partial volume effects cause some distortion of the VIF (66). The model was fit to the decaying
portion of the model after the initial rise of the contrast agent using a Levenberg-Marquardt
algorithm (116) in Matlab. To minimize the difficulties associated with the sensitivity of
biexponential fits to initial parameter values in fitting, a stripping algorithm was used (117). In
this approach, the slow component is first estimate solely from the last half of the data, which
should be approximately monoexponential due to decay of the fast component. This term is
then subtracted from the data to produce a set of data which should only include the fast
component, which can also be calculated. These parameters are then used as initial values for
the non-linear fit to the entire model and the entire set of data.
For each mouse, the coefficient of variation of each parameter was calculated for VIF
measurements. The mean coefficients of variation for the biexponential parameters were
compared using the paired Hotelling T2 test, which is the multivariate analogue of the paired ttest (118). As additional figures of interest, the CV of the parameters means across subjects
was calculated from the mean parameter values from each mouse.
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5.5.2 Results
The raw values for the biexponential model parameters for each technique are given in
Table 5-1 and Table 5-2, and are plotted in graphical format in Figure 5-2.
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kfast (1/min)
Mouse 1

Mouse 2

Mouse 3

Mouse 4

Mouse 5

Mouse 6

Mouse 7

Mouse 8

α

kslow (1/min)

C (µmol)

Injection 1

2.96

1.13

0.169

67

Injection 2

4.50

0.77

0.138

52

Injection 3

3.22

1.21

0.00

48

Injection 1

2.93

1.62

0.090

65

Injection 2

1.61

2.31

0.000

29

Injection 3

1.35

1.13

0.079

49

Injection 1

3.11

1.66

0.145

105

Injection 2

2.42

1.82

0.076

96

Injection 3

2.53

1.82

0.118

55

Injection 1

2.49

2.32

0.162

52

Injection 2

2.22

1.44

0.055

130

Injection 1

0.66

2.04

0.013
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Injection 2

1.03

1.98

0.029

79

Injection 1

0.93

3.54

0.000

61

Injection 2

1.10

1.92

0.183

64

Injection 3

0.53

1.34

0.139

53

Injection 1

0.71

1.64

0.065

77

Injection 2

0.49

1.28

0.083

79

Injection 1

2.37

2.94

0.059

355

Injection 2

2.60

2.03

0.225

38

Injection 3

5.24

2.28

0.049

26

Table 5-1 VIF descriptive parameters from the heart using constrained reconstruction
analysis.
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kfast (1/min)
Mouse 1

Mouse 2

Mouse 3

Mouse 4

Mouse 5

Mouse 6

Mouse 7

Mouse 8

α

kslow (1/min)

C (µmol)

Injection 1

0.83

1.1864

0.154

21

Injection 2

14.05

0.4236

0.291

25

Injection 3

15.57

0.7590

0.010

32

Injection 1

1.44

0.4616

0.056

50

Injection 2

1.16

0.7590

0.018

18

Injection 3

22.29

0.0000

0.169

33

Injection 1

2.81

0.9659

0.146

53

Injection 2

1.48

0.6980

0.068

45

Injection 3

3.96

0.6717

0.075

31

Injection 1

2.55

1.3365

0.130

53

Injection 2

2.43

0.9201

0.043

72

Injection 1

0.36

0.3240

0.049

99

Injection 2

0.15

0.0929

0.153

36

Injection 1

0.22

0.4868

0.216

80

Injection 2

1.36

0.2295

0.161

71

Injection 3

3.54

0.0000

0.085

42

Injection 1

1.05

0.8379

0.047

34

Injection 2

44.50

0.4067

0.72

39

Injection 1

0.99

0.3410

0.022

329

Injection 2

4.76

1.3436

0.120

33

Injection 3

0.11

0.4439

1.429

14

Table 5-2 Measured VIF descriptive parameters from the cerebral vessels with
conventional encoding.

117

Figure 5-2 Measured VIF parameters for all mice and injections.
Tighter clustering is found in the estimates from constrained reconstruction in the heart
(circles) than those made in local blood vessels using conventional encoding (diamonds),
demonstrating the superior reproducibility of the cardiac sampling. These differences are
most pronounced in comparisons of the fast component, which showed the most
improvement in reproducibility of the four parameters.
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kfast

α

kslow

C0

Mouse 1

23%

22%

88%

18%

Mouse 2

43%

35%

87%

38%

Mouse 3

14%

5%

31%

31%

Mouse 4

8%

33%

70%

60%

Mouse 5

31%

2%

52%

27%

Mouse 6

34%

50%

89%

10%

Mouse 7

26%

18%

17%

2%

Mouse 8

47%

20%

89%

133%

Table 5-3 Coefficients of variation of the parameters for the biexponential fits measured
in the heart using CACTUS acquisition and analysis.

kfast

α

kslow

C0

Mouse 1

80%

48%

93%

20%

Mouse 2

146%

94%

97%

47%

Mouse 3

45%

21%

45%

26%

Mouse 4

4%

26%

71%

21%

Mouse 5

59%

78%

73%

67%

Mouse 6

99%

102%

43%

31%

Mouse 7

135%

49%

29%

9%

Mouse 8

127%

78%

151%

141%

Table 5-4 Coefficients of variation of the parameters for the biexponential fits measured
in the cerebral vessels using conventional Fourier-encoded acquisition and processing.
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Mean

Mean

Intrasubject

Intrasubject

Intersubject

Intersubject

Value

Value

CV (Local

CV (Heart)

CV (Local

CV (Heart)

(Local

(Heart)

Vessel)

6.01

2.14

86%

28%

120%

58%

0.6042

1.82

62%

23%

51%

24%

0.17

0.09

75%

65%

97%

38%

57

81

45%

40%

55%

36%

Vessel)

Vessel)
kfast
min-1
α
kslow
min-1
C0
µmol
Table 5-5 Interanimal comparisons of the pharmacokinetic parameters.
The parameter values of the biexponential fits reveal a greater reproducibility, both
within and between animals, of the VIFs measured in the heart using CACTUS compared to
those measured in local vessels with conventional sampling. The biexponential parameters for
all mice are shown graphically in Figure 5-2. The measured VIFs, and the fits, are shown in
Figure 5-3 through Figure 5-10. The within-mouse reproducibility of injections was
considerably improved (p<0.05), with the CV of kfast and α decreasing the most, from 86% to
28% and 62% to 23% in constrained and local vessels, respectively, while the changes in both
kslow and C0 were a more modest 10% and 5%, respectively. The inter-subject variation was
also decreased for the four parameters, again most prominently in the fast time constant,
although the number of mice imaged was not sufficient to permit usable statistical comparisons.
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Coefficients of variation for each mouse and each technique are given in Table 5-3
for cardiac sampling and Table 5-4 for left ventricular measurements, and overall results are
summarized in Table 5-6. These figures include both errors due to measurements and also true
changes in the blood dynamics due to variation in the injections and drift in the physiological
state of the mouse, however, a reduction in the variance may be attributed to a reduction in
measurement error because of the paired nature of the measurements and physiological drift
will be common to both techniques.
Quantitative differences in the VIFs measured with the two techniques were observed,
indicated by the mean biexponential parameters differing between conventional vessel
sampling and cardiac sampling with constrained analysis (p<0.05). The mean concentration
measured in the heart was larger, which is consistent with a decrease in the presence of partial
volume and flow artifacts. The mean relative amplitude of the fast component was larger when
measured using constrained reconstruction in the heart, which is consistent with better
sampling of the peak, as was seen in both the proof-of-principle simulations and in the
comparison of FBP with the CR algorithm.
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Figure 5-3 VIFs measured in mouse 1.
In these VIFs, the curves from the constrained cardiac measurement present considerably
smaller signal fluctuations due to noise and motion. In the fits to the third local vessel
VIF, the fit of the fast component is noticeably brief, consisting of only a single point, as
evidenced by the very large decay constant for the curves.
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Figure 5-4 VIFs measured in mouse 2.
Motion is less problematic in the local vessel measurements in this mouse than in the
previous, although a few large signal jumps are visible. For the first two injections, the
initial peak of the VIF is noticeably more prominent in the cardiac measurements than in
the vascular ones.

123

Figure 5-5 VIFs measured in mouse 3.
Many of the same comments that apply to the first mice apply to these curves. Of
particular note is the second pair of measurements, where an initial peak of the contrast
agent that is clearly seen in the cardiac measurement is not resolved in the vessel
measurement. The second and third curves have secondary bumps which are consistent
with recirculation, although they are less distinct than in the first mouse.

124

Figure 5-6 VIFs measured in mouse 4.
Only two measurements were performed in this mouse due to substantial motion during
the third injection. Relatively large oscillations are found in the cardiac measurements,
although the relative magnitude of these is less than the artifacts found in the local vessel
measurements.
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Figure 5-7 VIFs measured in mouse 5.
These VIFs demonstrate relatively large fluctuations and are fairly low in amplitude.
Neither technique provided extremely high quality measurements in this mouse.
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Figure 5-8 VIFs measured in mouse 6.
The VIFs measured with both techniques display unusually broad initial regions, which
seems to widen with time. This may be due to drift in the physiology or some motion in
the catheter placement. The overall slow dynamics of these uptake curves render the
higher temporal resolution of the cardiac measurement less evident.
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Figure 5-9 VIFs measured in mouse 7.
The cardiac measurement proved more reproducible in this mouse, despite fairly noisy
measured VIFs. In particular, in this mouse the fast decay constant shows the largest
improvement with the cardiac measurement of any mouse.
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Figure 5-10 VIFs measured in mouse 8.
These uptake curves display unusually low relative amplitude slow phases. In the third
injection, the oscillations in the local vessel curve are often larger than the concentration
level itself, artifacts which are not found in the cardiac measurement. For both curves,
the first injection is of larger amplitude than the last two. This appears to be a legitimate
difference in the amount of contrast delivered due to substantial backwash of blood into
the catheter after the first injection.
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5.6 Comparison of different levels of low-pass filtering
5.6.1 Methods
Although the temporal resolution needed for VIF measurement in mice has not been
established, the raw output of the constrained reconstruction is certainly sampled sufficiently
rapidly to potentially satisfy any temporal resolution criteria for small animal DCE-MRI.
However, model fitting is sensitive to problems with local minima that result from noise (119).
Biexponential models, as will be used in this work, are known to be highly sensitive to this
effect, with unreliable results reported even for SNR levels of 70 (120), although those results
featured closer values of the two decay constants. To more reliably perform fits of in vivo data
to models, filtration was performed as described in §4.11. However, the range of reasonable
filtration choices is wide. Therefore, we performed a comparison of the reproducibility VIFs in
one mouse with both a 1 s filter and a 0.6 s filter. The biexponential fitting and CV calculation
was performed for the data from a single mouse.

5.6.2 Results
The two VIF signal curves agree closely (Figure 5-11), although the curve processed
with greater filtration is smoother and shows a lower noise level. Except for the fast decay
constant of the third injection, all parameter values agree to within 3%, and the coefficients of
variation derived from these parameters are nearly identical. These results indicate that the
measurement reproducibility in these mice does not depend strongly on the choice of the filter
used. Parameter values and corresponding variations are given in Table 5-6.
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Figure 5-11 Comparison of a VIF measured with two different filter widths.
The curves generated by two different filter widths align quite closely (top), and only
small fluctuations are seen in the difference curve (bottom).
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kfast (1/min)
0.6 s

1s

CV

α

kslow (1/min)

C (µmol)

Injection 1

3.21

1.70

0.147

105

Injection 2

2.50

1.87

0.077

95

Injection 3

2.75

1.86

0.119

56

Injection 1

3.11

1.66

0.145

105

Injection 2

2.42

1.82

0.076

96

Injection 3

2.53

1.82

0.118

55

1s

13%

5%

31%

31%

0.6 s

13%

5%

31%

30%

Table 5-6 Biexponential parameters calculated with two different filter widths applied.

5.7 Discussion
Robust and consistent VIF measurement is an outstanding challenge in small animal
MRI. We have developed a strategy for reduced artifact acquisition of the VIF that relies upon
measurement in the left ventricle, which provides resistance to partial volume effects and an
improved signal to noise ratio due to its large size, and by using a constrained reconstruction
approach, which provides high temporal resolution measurement of the VIF.
Our measurements of the VIF rise times indicate conventional encoding is not able to
reliably measure the VIF dynamics in mice. The rise times were substantially wider than the
width of the filter, indicating its effect on the measurement will be relatively slight.
Our measurements indicate a significant improvement in the within-mouse
reproducibility of VIF measurement, as quantified by analyzing the variations in a
biexponential representation of the VIF. The experimental setup was designed to maintain the
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stability of the animal’s physiology, ensuring that the variation in VIFs between
injections is dominated by measurement effects and not by physiological drift. Although
measurements were not performed of tumor enhancement, the VIF is an input into the
parameter calculation and is known to strongly affect the resulting parameters(11,57). In
addition, we observed both a reduction in the inter-animal variation and a significant change in
the shapes of the VIFs compared to conventional vessel sampling.
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6 Conclusions
6.1 Summary
This work consisted of three aims, with the objective of testing the hypothesis that
rapidly sampled measurements of the VIF in the heart would produce more reproducible
measurements than conventional local vessel sampling of the VIF. The first two aims involved
the implementation and development of the technical components necessary to accomplish
cardiac sampling of the VIF. The final aim was perform a comparison of the within-subject
variation of VIF measurement using the newly developed and conventional techniques.
The first aim was concerned with the development of a novel RF pulse to mitigate the
effects of flow enhancement on the VIF measurement. We considered two classes of pulses
that combine spatial presaturation of flowing spins with excitation. One used a symmetric
envelope of three sinc pulses; the other used an asymmetric envelope with a sinc pulse and a
cosine-modulated sinc pulse. Phantom data showed that both families of pulses were able to
reduce the signal of flowing water to its baseline level, however, simulations and measured data
showed that the asymmetric pulse tended to produce an show fluctuations with the width of the
sideband, rendering its suppression of out-of-slice signal suspect. For this reason, the
symmetric pulse was determined to be preferable and was used in the remainder of the
measurements in this body of work.
Our results also suggest that, while the use of this pulse is always able to increase the
sensitivity of the MR signal to the presence of contrast agent, some residual flow enhancement
in the case of straight-line flow may be present due to incomplete out-of-slice signal spoiling.
This was indicated in simulations and measurements in the inferior vena cava. Suppression of
flow enhancement in the left ventricle is less susceptible to this artifact because blood does not
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follow a straight-line path in the thorax, the entirety of which can be covered by the
presaturation region produced by the RF pulse. Blood enters the thorax through the vena cava
and passes through the other three chambers of the heart and the lungs before arriving in the
left ventricle. This both extends the effective width of the saturation region and prevents the
signal bias from interfering with the measurement in the left ventricle.
Final measurements in the first aim demonstrate the that a VIF measured in the heart
shows a much larger signal increase when measured with the composite pulse than with a sinc
pulse with no additional flow suppression. Even in data sampled at low temporal resolution,
the flow suppressed VIF showed more structure than the VIF acquired with conventional
excitation. This both underscores the importance of flow enhancement suppression to VIF
measurement and demonstrates the ability of this pulse to provide efficient flow suppression
without sacrificing excessive time during the pulse sequence.
The second aim was devoted to the development of CACTUS, an anatomically
constrained approach to data analysis which allows sampling of the signal from the left
ventricle at extremely rapid rates. This technique relies upon the use of a manual segmentation
to provide prior information that is used to reconstruct an approximate measure of the mean
signal in each ROI.
Numerical simulations of the algorithms show that it is insensitive to random variations
in the dynamics of the tissue. Non-random variations in the tissue dynamics, such as would
result from segmentation errors, can produce artifacts, although these may be mitigated by the
use of multiple projections. Phantom and in vivo measurements indicate accuracy to within 4%
of the actual value in many cases when using a two projection protocol. The use of CACTUS
was found to provide higher temporal resolution measurement of the VIF than full encoding,
while capturing the low temporal resolution dynamics comparable to a full acquisition. This
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technique was in fact able to identify the first pass of the contrast agent in mice,
although recirculation of the contrast agent was not identifiable.
With these technical developments, we performed a reproducibility study of VIFs
measured in small animal models. Measurements made with the techniques were compared to
measurements made in blood vessels in the head and neck region using conventional sampling
techniques. We found a statistically significant improvement (p < 0.05) in the intra-subject
reproducibility, with the CV of model parameters decreasing by up to 56%. We also observed
an improvement in the inter-subject reproducibility, although we did not image a sufficient
number of mice to perform rigorous statistical comparisons.

6.2 Hypothesis
Our in vivo comparisons found a statistically significant reduction in the coefficients of
variation of the biexponential parameters of VIFs measured using the techniques described here
as compared to measurements in a local blood vessel. We also achieved sub-second temporal
resolution of the measurement. Based on these two points, we find that that hypothesis is
supported by the data.

6.3 Limitations and Future work
The comparison of VIF reproducibility was between measurements made in the heart
with the developed techniques and measurements made with a conventional vessel
measurement. Only a limited number of voxels were used in the measurements of the local
vessel VIFs, which is a contributor to the noise of these measurements, although this is in part
due to the greater volume of blood available in the heart for VIF measurement and in part a
reflection of the difficulty in finding blood vessels that had similar VIF amplitudes and whose
time courses were not offset in time. The reliability of the local vessel measurements could
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have been improved by the use of dedicated flow suppression techniques to
minimize inflow artifacts in those measurements, however, an objective of this work was to
measure VIFs without the compromise in slice coverage that would be required. This rendered
truly paired results impossible. Additionally, we found a substantial attenuation of inflow
enhancement in local vessels due to residual saturation from the spin preparation in the thorax.
For these reasons, the overall conclusion that a substantial improvement in VIF measurement is
achieved with this technique is still valid.
Our technique provided considerably more reproducible measurements of the VIF than
conventional measurements. Although it is expected that these techniques should lead to an
improvement in the measurement of pharmacokinetic parameters, this was not directly
demonstrated. In vivo testing with a tumor model would provide additional characterization of
the technique and a more direct indication of the extent to which it improves upon existing
techniques. However, those measurements are outside the scope of this work.
Further improvements to the technique are also possible. Because of the decreased
signal from the ventricles, conventional filters for approaches to retrospective cardiac gating
were not able to reduce the signal fluctuations due to cardiac motion. We reduced cardiac
motion artifacts with a low pass filter, however, this decreased our temporal resolution. More
intelligent denoising approaches, such as a Wiener filter (121) or wavelet-based approaches
(122) may be more suitable this application.
The techniques used in this work allow the potential for very high temporal resolution.
However, there is no established rate at which the temporal resolution of VIF measurement for
use in pharmacokinetic parameter calculation in mice is optimized. Simulations should be
performed to establish a required sampling rate for a given accuracy of the final parameters, as
has been done in humans (56).
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This work used the same acquisition protocols for both the tissue slices and
the cardiac slice using interleaved encoding schemes, except for the k-space trajectory.
However, the contrast agent concentrations reach higher peak levels in blood than they do in
tissue, resulting in shorter relaxation times. As a result, larger flip angles are needed for
optimal imaging of contrast agent concentrations in the blood than are needed for tissue (31).
Because a separate slice is used for VIF measurement with the approach implemented here, the
use of a different excitation angle for each is easily achieved, and consideration of these effects
may lead to further improvements in VIF measurement.

6.4 Conclusions
We have developed a set of tools to address what has been called “a notoriously
difficult problem” (71). Artifacts, such as inflow enhancement and partial volume effects, as
well as limitations in the achievable temporal resolution, compromise the integrity of the VIFs
used in small animal DCE-MRI studies. The techniques developed in this work have shown
that they are capable of producing more reproducible measurements of the vascular input
function, which will lead to more reliable and robust measurements of DCE-MRI
pharmacokinetic parameters.
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Appendix: Matlab reconstruction code
function getAIFheart(varargin)
%% Front matter
%Here are the parameters this function uses:
grouping = 2; %Number of projections to use per constrained time point
%It needs to divide the number of spokes
liverind = 4; %ROI position of the liver; should be 4
respthresh = .3; %Percentage of points to discard for respiratory triggering
order = 0; %Order of the Taylor polynomial
%% Identify the directory to process
if nargin==0
dirname = uigetdir;
else
dirname = varargin{1};
if isnumeric(dirname)
dirname = num2str(dirname);
end
end
%% Read in and reconstruct filtered backprojection images
tic
fbpname = fullfile(dirname, 'fbp.mat');
if exist(fbpname)
load(fbpname, 'this');
else
this = readHybridData(dirname);
save(fbpname, 'this');
end
toc
% a=questdlg('Continue to segmentation?');
% if ~(a(1)=='Y')
%
return
% end
%% Perform manual segmentation
roisname = fullfile(dirname, 'rois.mat');
if exist(roisname)
load(roisname, 'rois');
else
%Choose the image with the greatest overall increase in image intensity
temp = abs(squeeze(sum(sum(this.radimg, 1), 2)));
gradient(2:length(temp)) = temp(2:end)-temp(1:end-1);
argpeak = find(gradient==max(gradient));
rois = guidedManualSegmentation(sum(this.radimg, 3));
%
rois = guidedManualSegmentation(abs(this.radimg(:, :, argpeak)));
save(roisname, 'rois');
end
%% Expand ROIs
tic
%Expand ROI 1
radius = 1;
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old1 = rois(:, :, 1);
expansion = rois(:, :, 1);
contraction = ~rois(:, :, 1);
for ind = radius:-1:1
contraction(2:end-1, :, 1) = contraction(2:end-1, :, 1) |
contraction(1:end-2, :, 1) | contraction(3:end, :, 1);
contraction(:, 2:end-1, 1) = contraction(:, 2:end-1, 1) | contraction(:,
1:end-2, 1) | contraction(:, 3:end, 1);
end
contraction = ~contraction;
rois(:, :, 1) = contraction;
rois(:, :, 11) = expansion&~contraction;
for ind = 2:10
rois(:, :, ind) = rois(:, :, ind)&~rois(:, :, 11);
end
%% Raw constrained reconstruction
[Nfreq Ntheta Nframe] = size(this.proj);
Nrois = size(rois, 3);
Ngroups = Ntheta/grouping;
Npoints = Nframe*Ngroups;
this.theta = reshape(this.theta, Ntheta, Nframe);
indices = reshape(1:Ntheta, grouping, Ngroups);
%For the Taylor expansion version
nterms = (order+2)*(order+1)/2;
[x, y] = ndgrid(linspace(-1, 1, size(rois, 1)), linspace(-1, 1, size(rois,
2)));
n = nterms;
for indO = order:-1:0
for indP = indO+1:-1:1
geom(:, :, n) = x.^(indP-1).*y.^(indO-indP+1);
n = n-1;
end
end

for ind = Nframe:-1:1
refimg = this.radimg(:, :, ind);
A = dPrepareConstrainedRecoTaylor(this.theta(:, ind), rois, (refimg));
%

A2 = dPrepareConstrainedReco(this.theta(:, ind), rois, refimg2);
support = dPrepareConstrainedReco(this.theta(:, ind), any(rois, 3),
ones(size(refimg)))>0;
support = reshape(support, size(support, 1)*grouping, Ngroups);
heartros = dPrepareConstrainedReco(this.theta(:, ind), any(rois(:, :,
1:3), 3), ones(size(refimg)))>0;
%
A = reshape(A, Nfreq, Nrois, grouping, Ngroups);
projections = reshape(this.proj(:, :, ind), Nfreq, grouping, Ngroups);
offset = (size(A, 1)-size(projections, 1))/2;
projections = cat(1, zeros(floor(offset), grouping, Ngroups),
projections, zeros(ceil(offset), grouping, Ngroups));
for ind2 = Ngroups:-1:1
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[tempz(:, :, ind2) condsigs(:, ind2, ind) res(:, ind2,
ind)] = dPerformConstrainedReconTaylor((projections(:, :, ind2)), A,
indices(:, ind2), [], rois, refimg);
end
thisimg = this.radimg(:, :, ind);
res(:, :, ind) = res(:, :, ind).*support;
ravg(:, ind) = mean(abs(res(:, :, ind)))./mean(support);
heartros = reshape(heartros, size(projections));
heartsig(:, :, :, ind) = projections.*heartros;
heartres(:, :, ind) = res(:, :, ind).*reshape(heartros, size(res, 1),
size(res, 2));
for ind2 = Nrois:-1:1
fbpsigs(ind2, ind) = mean(thisimg(rois(:, :, ind2)));
end
end
condsigs = reshape(condsigs, Nrois, Npoints);
condsigs(isnan(condsigs))=0;
cutoffind = round(respthresh*Ngroups);
liverpresent = any(any(rois(:, :, liverind), 1), 2);
if liverpresent
liversigs = reshape(condsigs(liverind, :), Ngroups, Nframe);
for ind = Nframe:-1:1
fastliver = abs(liversigs(:, ind))-abs(fbpsigs(liverind, ind));
temp = sort(fastliver);
threshold = temp(cutoffind);
respgate(:, ind) = fastliver>threshold;
end
else
respgate = true(Ngroups, Nframe);
end
respgate = respgate(:);
for ind = 2:length(respgate)-1
if respgate(ind-1)&respgate(ind+1)
respgate(ind) = true;
end
end
for ind = 2:length(respgate)-1
if ~respgate(ind-1)&~respgate(ind+1)
respgate(ind) = false;
end
end
%% Perform despiking

%% Perform cardiac triggering
% respgate(:) = true;
heartsig
Ngroups,
tempgate
tempgate

= reshape((sum(heartsig, 1))./sum(abs(heartsig)>1, 1), grouping,
Nframe);
= repmat(respgate, [1 grouping])';
= reshape(tempgate, grouping, Ngroups, Nframe);
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for ind = Nframe:-1:1
temp = heartsig(:, :, ind);
temp = temp(tempgate(:, :, ind));
timedrift(1, ind) = mean(angle(temp));
end
heartsig = reshape(heartsig, Ntheta, Nframe);
tempgate = reshape(tempgate, Ntheta, Nframe);
for ind = Ntheta:-1:1
temp = heartsig(ind, :);
temp = temp(tempgate(ind, :));
spacedrift(ind, 1) = mean(angle(temp));
end
heartphase = angle(heartsig)-repmat(timedrift, [Ntheta 1])repmat(spacedrift, [1 Nframe]);
heartphase = heartphase-mean(heartphase(tempgate(:)));
temp = heartphase(:);
threshold = std(temp(tempgate(:)))/2;
cgate = abs(heartphase)<threshold;
cardiacgate = all(reshape(cgate, grouping, []), 1)';
%% Perform residual gating
% ravg = reshape(mean(abs(res), 1), [], 1);
% rgate = false(size(ravg));
% rgate(2:end-1) = (ravg(2:end-1)<ravg(1:end-2)) & (ravg(2:end1)<ravg(3:end));
%% Filter
%Create a list of filterwidths
duration = Ntheta*Nframe*this.method.PVM_RepetitionTime/1000/60; %in minutes
tslow = linspace(0, duration, Nframe);
tfast = linspace(0, duration, Npoints);
fbpvif = abs(fbpsigs(1, :));
lvslow = interp1(tslow, fbpvif, tfast);
weights = (lvslow/min(lvslow(:))).^1;
% lvslow = lvslow-min(lvslow(:));
%
%
%
%
%
%
%

for ind = Npoints:-1:1
percentile(ind) = sum(lvslow(ind)>lvslow)/Npoints;
end
weights = (log(100*percentile+exp(3))-2).^1.5;
%Alternate approach
weights = 4*lvslow/max(lvslow(:))+1;

lvsig = condsigs(1, :);
rvsig = condsigs(3, :);
filteredsig = zeros(size(lvsig));
windowwidth = 24/grouping;
%Hack to disable respgating
% respgate(:) = true;
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% windowwidth = 1;
weights(:) = 1;
for ind = Npoints:-1:1
if respgate(ind)
thiswidth = round(windowwidth/weights(ind));
imax = min(Npoints, ind+thiswidth);
imin = max(1, ind-thiswidth);
localgate = respgate(imin:imax);
localsigs = lvsig(imin:imax);
filteredsig(ind) = mean(localsigs(localgate));
localrsigs = rvsig(imin:imax);
rvfilt(ind) = mean(localrsigs(localgate));
tw(ind) = thiswidth;
end
end
plot(tfast(respgate), abs(filteredsig(respgate)), tslow, fbpvif)
vifname = fullfile(dirname, 'heartvif.mat');
save(vifname, 'condsigs', 'filteredsig', 'tfast', 'tslow', 'fbpvif',
'respgate', 'res', 'heartsig', 'ravg', 'heartres', 'heartphase', 'rvfilt',
'rois');
toc
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function this = readHybridData(indir)
this = readBrukerDirectory(indir);
Nx = this.method.PVM_Matrix(1);
Ny = this.method.PVM_Matrix(2);
Ntheta = this.method.nTheta;
Nreps = this.method.PVM_NRepetitions;
deltatheta = this.method.loopskip;
Nslices = this.method.PVM_SPackArrNSlices(1); %Number of Cartesian slices
this.fid = reshape(this.fid, Nx, Nslices+1, Ny, Nreps); %For now, just
assume that there is only one radial slice
this.fid = permute(this.fid, [1 3 2 4]);
this.radfid = squeeze(this.fid(:, :, end, :));
n = Ny*Nreps;
thetaind = mod((0:(n-1))*deltatheta, Ntheta)+1;
theta = (thetaind-1)*180/Ntheta;
if isfield(this.method, 'cover')
if strncmp(this.method.cover, 'Full', 4)
theta(2:2:end) = theta(2:2:end)+180;
%
this.fid(:, 2:2:end, :, :) = this.fid(end:-1:1, 2:2:end, :, :);
end
end
nRadImg = floor(Ny*Nreps/Ntheta); %Number of fully encoded radial images
fid = this.radfid;
proj = fftshift(ifft(ifftshift(fid), [], 1));
ptemp = mean(mean(proj, 2), 3);
ptemp = exp(i*angle(ptemp));
proj = proj./repmat(ptemp, [1 Ny Nreps]);
proj = reshape(proj, Nx, []);
proj = proj(:, 1:(Ntheta*nRadImg));
proj = reshape(proj, Nx, Ntheta, nRadImg);
proj = reshape(proj, Nx, Ntheta, nRadImg);
for ind = nRadImg:-1:1
tind = Ntheta*(ind-1)+(1:Ntheta);
cimg(:, :, ind) = iradon(real(proj(:, :, ind)), theta(tind), 'Ram-Lak',
'Linear', 1, Nx) + ...
i*iradon(imag(proj(:, :, ind)), theta(tind), 'Ram-Lak', 'Linear', 1,
Nx);
%
cimg(:, :, ind) = iradon(abs(proj(:, :, ind)), theta(tind), 'Ram-Lak',
'Linear', 1, Nx);
end
this.proj = proj;
this.theta = theta;
this.thetaind = thetaind;
this.radimg = cimg;
%% Deal with body images
fid = this.fid(:, :, 1:end-1, :);
img = fftshift(fftshift(ifft2(ifftshift(ifftshift(fid, 1), 2)), 1), 2);
this.img = img;
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function output = readBrukerDirectory(directory, varargin)
if nargin == 0
directory = uigetdir('/~', 'Directory for Dixon data');
end
if(directory(end)~='/')
directory = [directory '/'];
end
output.acqp = readBrukerHeader([directory 'acqp']);
output.method = readBrukerHeader([directory 'method']);
output.fid = readBrukerFID(directory, output.method);
output.subject = readBrukerHeader([directory '../subject']);
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function struct = readBrukerHeader(filename)
fid = fopen(filename, 'r', 'l');
if (fid==-1)
error('File not found in readBrukerHeader');
end

rawitems = textscan(fid, '%s', 'Delimiter', '\n');
fclose(fid);
rawitems = rawitems{1};
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%

rawdata = fread(fid, Inf, 'char=>char')';
fclose(fid);
temp = rawdata;
index = 1;
while ~isempty(temp)
[thisstring temp] = strtok(temp, sprintf('\n'));
if(strncmp(thisstring(end:-1:1), '$$', 2))
thisstring = thisstring(1:end-2);
end
rawitems{index} = thisstring;
index = index+1;
end

index = 1;
while index<=length(rawitems)
offset = 0;
thisstring = rawitems{index};
%The next line is a hack. I'm okay with that.
%Account for comment lines and other special cases
if(strncmp(thisstring, '$$ @vis', 7))
index = index + 1;
continue
end
if(strncmp(thisstring, '##END=', 6))
break
end
%Test that we're on a variable definition lines
if(strncmp(thisstring, '##', 2))
[name value] = strtok(thisstring, '=');
%Trim off special characters
name = name(3:end);
if(name(1)=='$')
name = name(2:end);
end
if ~isvarname(name)
name = genvarname(name);
end
value = value(2:end);
%Here's the case of just one item
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if(~any(value=='('))
num = str2num(value);
if ~isempty(num)
struct.(name) = num;
else
struct.(name) = value;
end
index = index+1;
continue
end
%Now, consider the case of a string
if(rawitems{index+1}(1)=='<')
struct.(name) = rawitems{index+1}(2:end-1);
index = index + 1;
continue
end
%Check for an array
if(strncmp(value, '( ', 2))
array_is_numeric = true;
%Parse the dimension description
size = str2num(value(3:end-1));
if(isscalar(size))
size = [1 size];
end
n = prod(size);
offset = 1;
data = [];
while (rawitems{index+offset}(1)~='#') &&
(rawitems{index+offset}(1)~='$')
data = [data rawitems{index+offset}];
offset = offset+1;
end
for index2 = 1:n
[temptemp, data] = strtok(data);
if(strncmp(temptemp((end-1):-1:1), '$$', 2))
temptemp = temptemp(1:end-2);
end
num = str2num(temptemp);
if isempty(num)
array{index2} = temptemp;
array_is_numeric = false;
else
array{index2} = num;
end
end
if(array_is_numeric)
array = cell2mat(array);
end
array = reshape(array, size);
if n==1 && iscell(array)
array = array{1};
end
struct.(name) = array;
clear array
index = index + offset;
continue
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end
%Check for a cell array analogue
if(strncmp(value, '(', 1))
data = value(2:end);
while ~any(data==')')
offset = offset+1;
data = [data rawitems{index+offset}];
end
data = data(1:end-1);
index = index + offset;
struct.(name) = data;
end
%Lastly, handle XYPOINTS
if(strcmp(name, 'XYPOINTS'))
offset = 1;
ok = 1;
while(ok)
[data ok] = str2num(rawitems{index+offset});
if(ok)
struct.XYPOINTS(offset, 1:2) = data;
end
offset = offset + 1;
end
index = index + offset;
end
end
index = index+1;
end
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function fid = readBrukerFID(directory, varargin)

filename = fullfile(directory, 'fid');
fileid = fopen(filename, 'r', 'l');
fid = fread(fileid, Inf, 'int32');
fclose(fileid);
fid = fid(1:2:end) + i*fid(2:2:end);
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function rois = guidedManualSegmentation(refimg)
s.Default = 'Ok';
s.Interpreter = 'tex';
lv = false(size(refimg));
lvmyo = false(size(refimg));
heart = false(size(refimg));
vess = false(size(refimg));
portalvess = false(size(refimg));
allliver = false(size(refimg));
chest = false(size(refimg));
muscle = false(size(refimg));
body = false(size(refimg));
waterbed = false(size(refimg));
refimg = abs(refimg)/max(abs(refimg(:)));
answer = questdlg('Please contour the \bf{left ventricle}', 'Contouring',
'Ok', 'Not Present', 'Stop Now', s);
n = parse(answer);
if n == 0
lv = roipoly(refimg);
close(gcf);
elseif n == 2
rois = stackROIs(lv, lvmyo, heart, vess, portalvess, allliver, chest,
muscle, body, waterbed);
return
end
answer = questdlg('Please contour the \bf{outside of the myocardium}',
'Contouring', 'Ok', 'Not Present', 'Stop Now', s);
n = parse(answer);
if n == 0
lvmyo = roipoly(refimg);
close(gcf);
elseif n == 2
rois = stackROIs(lv, lvmyo, heart, vess, portalvess, allliver, chest,
muscle, body, waterbed);
return
end
answer = questdlg('Please contour the \bf{entire heart}', 'Contouring',
'Ok', 'Not Present', 'Stop Now', s);
n = parse(answer);
if n == 0
heart = roipoly(refimg);
close(gcf);
elseif n == 2
rois = lv;
return
end
answer = questdlg('Please contour any \bf{great vessels} present',
'Contouring', 'Ok', 'Not Present', 'Stop Now', s);
n = parse(answer);
if n == 0
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vess = roipoly(refimg);
close(gcf);
elseif n == 2
rois = stackROIs(lv, lvmyo, heart, vess, portalvess, allliver, chest,
muscle, body, waterbed);
return
end
answer = questdlg('Please contour any \bf{liver vessels} present',
'Contouring', 'Ok', 'Not Present', 'Stop Now', s);
n = parse(answer);
if n == 0
portalvess = roipoly(refimg);
close(gcf);
elseif n == 2
rois = stackROIs(lv, lvmyo, heart, vess, portalvess, allliver, chest,
muscle, body, waterbed);
return
end
answer = questdlg('Please contour the \bf{liver}', 'Contouring', 'Ok', 'Not
Present', 'Stop Now', s);
n = parse(answer);
if n == 0
allliver = roipoly(refimg);
close(gcf);
elseif n == 2
rois = stackROIs(lv, lvmyo, heart, vess, portalvess, allliver, chest,
muscle, body, waterbed);
return
end
answer = questdlg('Please contour the \bf{chest cavity}', 'Contouring',
'Ok', 'Not Present', 'Stop Now', s);
n = parse(answer);
if n == 0
chest = roipoly(refimg);
close(gcf);
elseif n == 2
rois = stackROIs(lv, lvmyo, heart, vess, portalvess, allliver, chest,
muscle, body, waterbed);
return
end
answer = questdlg('Please contour the \bf{body without fat layer}',
'Contouring', 'Ok', 'Not Present', 'Stop Now', s);
n = parse(answer);
if n == 0
muscle = roipoly(refimg);
close(gcf);
elseif n == 2
rois = stackROIs(lv, lvmyo, heart, vess, portalvess, allliver, chest,
muscle, body, waterbed);
return
end
answer = questdlg('Please contour the \bf{entire body}', 'Contouring', 'Ok',
'Not Present', 'Stop Now', s);
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n = parse(answer);
if n == 0
body = roipoly(refimg);
close(gcf);
elseif n == 2
rois = stackROIs(lv, lvmyo, heart, vess, portalvess, allliver, chest,
muscle, body, waterbed);
return
end
answer = questdlg('Please contour the \bf{waterbeds}', 'Contouring', 'Ok',
'Not Present', 'Stop Now', s);
n = parse(answer);
if n == 0
waterbed = roipoly(refimg);
close(gcf);
end
rois = stackROIs(lv, lvmyo, heart, vess, portalvess, allliver, chest,
muscle, body, waterbed);
end
function n = parse(answer)
switch answer
case 'Ok'
n = 0;
case 'Not Present'
n = 1;
case 'Stop Now'
n = 2;
end
end
function rois = stackROIs(lv, lvmyo, heart, vess, portalvess, allliver,
chest, muscle, body, waterbed)
myo = lvmyo&~lv;
rv = heart&~(lv|lvmyo);
liver = allliver&~portalvess;
lungs = chest&~(lv|lvmyo|heart|vess|portalvess|allliver);
muscle = muscle&~(lv|lvmyo|heart|vess|portalvess|allliver|chest);
body = body&~(lv|lvmyo|heart|vess|portalvess|allliver|chest|body);
waterbed =waterbed&~body;
rois(:, :, 1) = lv;
rois(:, :, 2) = myo;
rois(:, :, 3) = rv;
rois(:, :, 4) = liver;
rois(:, :, 5) = vess;
rois(:, :, 6) = portalvess;
rois(:, :, 7) = muscle;
rois(:, :, 8) = body;
rois(:, :, 9) = waterbed;
rois(:, :, 10) = lungs;
end
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function [weights] = dPrepareConstrainedRecoTaylor(theta, segments,
img0, varargin)
%dPrepareConstrainedReco(theta, segments, img0, varargin)
%Flags is true if we are going to assume a constant value over the ROI
%First determine what format the rois are in...
if ~islogical(segments)
%Convert indices into ROIs
els = unique(segments(:));
for ind = length(els):-1:1
rois(:, :, ind) = segments==els(ind);
end
else
rois = segments;
end
order = 0;
nterms = (order+2)*(order+1)/2;
if nargin==3
flags = false(1, size(rois, 3));
else
flags = varargin{1};
end
[x, y] = ndgrid(linspace(-1, 1, size(rois, 1)), linspace(-1, 1, size(rois,
2)));
n = nterms;
%Hack for the case of using one line of Cartesian data
for indO = order:-1:0
for indP = indO+1:-1:1
geom = x.^(indP-1).*y.^(indO-indP+1);
if theta == 90
for ind = size(rois, 3):-1:1
thisroi = rois(:, :, ind).*geom;
if flags(ind)
weights(:, :, n, ind) = sum(thisroi,
2)*mean(img0(thisroi));
else
weights(:, :, n, ind) = sum(thisroi.*img0, 2);
end
end
elseif theta ==0
for ind = size(rois, 3):-1:1
thisroi = rois(:, :, ind).*geom;
if flags(ind)
weights(:, :, n, ind) = sum(thisroi,
1)*mean(img0(thisroi));
else
weights(:, :, n, ind) = sum(thisroi.*img0, 1);
end
end
else
for ind = size(rois, 3):-1:1
thisroi = rois(:, :, ind).*geom;
if flags(ind)
%
weights(:, :, ind) = radon(temp, theta);
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weights(:, :, n, ind) = radon(thisroi,
theta)*mean(img0(thisroi));
else
weights(:, :, n, ind) = radon(thisroi.*real(img0),
theta)+i*radon(thisroi.*imag(img0), theta);
end
end
end
n = n - 1;
end
end
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